stilbenoid - Ontology Report - Rat Genome Database

Submit Data | Help | Video Tutorials | News | Publications | Download | REST API | Citing RGD | Contact

CHEBI ONTOLOGY - ANNOTATIONS

{{ watchLinkText }}

The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.

Term:	stilbenoid	go back to main search page
Accession:	CHEBI:26776	browse the term
Definition:	Any olefinic compound characterised by a 1,2-diphenylethylene backbone.
Synonyms:	related_synonym:	stilbenes; stilbenoids
	alt_id:	MESH:D013267
	xref_mesh:	MESH:D013267

show annotations for term's descendants Sort by:
Rat (8329) Mouse (8525) Human (8840) Chinchilla (0) Bonobo (0) Dog (8) Squirrel (0) Pig (229) Green Monkey (0) Naked Mole-rat (0) All
Genes (229)

resveratrol

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

actin binding LIM protein 1

multiple interactions

[Dietary Fats co-treated with Resveratrol] results in increased expression of ABLIM1 mRNA

NCBI chr14:124,759,811...125,108,722
Ensembl chr14:124,760,404...125,010,892

G

aggrecan

decreases degradation

Resveratrol results in decreased degradation of ACAN protein

NCBI chr 7:54,449,830...54,520,606
Ensembl chr 7:54,449,816...54,519,194

G

androglobin

multiple interactions

[Dietary Fats co-treated with Resveratrol] results in increased expression of ADGB mRNA

NCBI chr 1:18,870,880...19,030,983
Ensembl chr 1:18,870,884...19,029,417

G

adhesion G protein-coupled receptor D1

multiple interactions

Resveratrol inhibits the reaction [Dietary Fats results in increased expression of ADGRD1 mRNA]

NCBI chr14:24,059,667...24,241,270
Ensembl chr14:24,059,019...24,241,176

G

AT-rich interaction domain 1B

multiple interactions

[Dietary Fats co-treated with Resveratrol] results in decreased expression of ARID1B mRNA

NCBI chr 1:9,791,627...10,227,381
Ensembl chr 1:9,791,633...10,227,502

G

cAMP regulated phosphoprotein 21

multiple interactions

Resveratrol inhibits the reaction [Dietary Fats results in increased expression of ARPP21 mRNA]

NCBI chr13:20,955,414...21,088,424
Ensembl chr13:20,934,846...21,088,420

G

arylsulfatase G

multiple interactions

[Dietary Fats co-treated with Resveratrol] results in increased expression of ARSG mRNA

NCBI chr12:11,751,930...11,882,844
Ensembl chr12:11,751,937...11,843,055

G

ASH2 like, histone lysine methyltransferase complex subunit

multiple interactions

Dietary Fats promotes the reaction [Resveratrol results in decreased expression of ASH2L mRNA]

NCBI chr15:48,386,426...48,417,560
Ensembl chr15:48,386,425...48,417,547

G

asparagine synthetase (glutamine-hydrolyzing)

multiple interactions

Resveratrol inhibits the reaction [Dietary Fats results in increased expression of ASNS mRNA]

NCBI chr 9:77,318,341...77,336,290
Ensembl chr 9:77,318,213...77,343,035

G

ATPase H+ transporting V1 subunit G2

multiple interactions

[Dietary Fats co-treated with Resveratrol] results in decreased expression of ATP6V1G2 mRNA

NCBI chr 7:23,670,970...23,673,860
Ensembl chr 7:23,670,965...23,673,837

G

BCL2 associated X, apoptosis regulator

increases expression

Resveratrol results in increased expression of BAX protein

NCBI chr 6:54,222,341...54,228,150
Ensembl chr 6:54,222,336...54,228,140

G

butyrylcholinesterase

multiple interactions

[Dietary Fats co-treated with Resveratrol] results in increased expression of BCHE mRNA

NCBI chr13:104,946,732...105,007,568

G

brain expressed, X-linked 1

multiple interactions

Resveratrol inhibits the reaction [Dietary Fats results in increased expression of BEX2 mRNA]

NCBI chr X:84,223,041...84,224,583
Ensembl chr X:84,222,959...84,224,613

G

brain expressed X-linked 3

multiple interactions

Resveratrol inhibits the reaction [Dietary Fats results in increased expression of BEX3 mRNA]

NCBI chr X:84,300,645...84,302,124
Ensembl chr X:84,300,645...84,302,119

G

brain expressed X-linked 4

multiple interactions

Resveratrol inhibits the reaction [Dietary Fats results in increased expression of BEX4 mRNA]

NCBI chr X:84,147,133...84,148,680
Ensembl chr X:84,147,183...84,149,084

G

caldesmon 1

multiple interactions

[Dietary Fats co-treated with Resveratrol] results in increased expression of CALD1 mRNA

NCBI chr18:14,267,955...14,486,641
Ensembl chr18:14,267,959...14,486,726

G

calcyphosine like

multiple interactions

[Dietary Fats co-treated with Resveratrol] results in decreased expression of CAPSL mRNA

NCBI chr16:21,349,279...21,356,670
Ensembl chr16:21,345,366...21,356,670

G

caspase 3

increases cleavage

Resveratrol results in increased cleavage of CASP3 protein

NCBI chr15:45,744,320...45,753,252
Ensembl chr15:45,742,751...45,764,213

G

catalase

multiple interactions

Resveratrol inhibits the reaction [Lipopolysaccharides results in decreased expression of CAT mRNA]

NCBI chr 2:26,493,664...26,533,881
Ensembl chr 2:26,487,653...26,581,452

G

caveolae associated protein 2

multiple interactions

[Dietary Fats co-treated with Resveratrol] results in increased expression of CAVIN2 mRNA

NCBI chr15:96,476,675...96,490,231
Ensembl chr15:96,474,284...96,490,016

G

coiled-coil domain containing 88A

multiple interactions

Resveratrol inhibits the reaction [Dietary Fats results in decreased expression of CCDC88A mRNA]

NCBI chr 3:85,811,043...85,971,162
Ensembl chr 3:85,811,127...85,941,864

G

chemokine (C-C motif) ligand 2

multiple interactions

Resveratrol inhibits the reaction [Dietary Fats results in increased expression of CCL2 mRNA]

NCBI chr12:40,798,109...40,800,013
Ensembl chr12:40,798,109...40,800,026

G

chemokine (C-C motif) ligand 8

multiple interactions

[Dietary Fats co-treated with Resveratrol] results in decreased expression of CCL8 mRNA

NCBI chr12:40,740,468...40,741,970
Ensembl chr12:40,740,023...40,742,022

G

C-C motif chemokine receptor 2

multiple interactions

[Dietary Fats co-treated with Resveratrol] results in increased expression of CCR2 mRNA

NCBI chr13:29,368,735...29,374,564
Ensembl chr13:29,285,012...29,376,343

G

C-C motif chemokine receptor 9

multiple interactions

[Dietary Fats co-treated with Resveratrol] results in decreased expression of CCR9 mRNA

NCBI chr13:29,033,609...29,051,227
Ensembl chr13:29,033,570...29,054,598

G

CD28 molecule

multiple interactions

[Dietary Fats co-treated with Resveratrol] results in increased expression of CD28 mRNA

NCBI chr15:107,128,103...107,155,431
Ensembl chr15:107,128,203...107,162,935

G

CDC42 binding protein kinase alpha

multiple interactions

[Dietary Fats co-treated with Resveratrol] results in increased expression of CDC42BPA mRNA

NCBI chr10:14,649,278...14,940,988
Ensembl chr10:14,652,855...14,940,825

G

cell division cycle associated 7

multiple interactions

[Dietary Fats co-treated with Resveratrol] results in decreased expression of CDCA7 mRNA

NCBI chr15:79,406,837...79,447,571
Ensembl chr15:79,432,667...79,447,568

G

cyclin dependent kinase 6

multiple interactions

Resveratrol inhibits the reaction [Dietary Fats results in increased expression of CDK6 mRNA]

NCBI chr 9:72,510,858...72,765,631
Ensembl chr 9:72,518,101...72,764,129

G

CDK5 regulatory subunit associated protein 1 like 1

multiple interactions

[Dietary Fats co-treated with Resveratrol] results in decreased expression of CDKAL1 mRNA

NCBI chr 7:15,910,645...16,569,643
Ensembl chr 7:15,910,666...16,626,276

G

CCAAT enhancer binding protein delta

multiple interactions

[Dietary Fats co-treated with Resveratrol] results in increased expression of CEBPD mRNA

NCBI chr 4:79,872,863...79,874,481
Ensembl chr 4:79,872,939...79,874,477

G

centromere protein E

multiple interactions

[Dietary Fats co-treated with Resveratrol] results in decreased expression of CENPE mRNA

NCBI chr 8:117,888,968...117,965,325
Ensembl chr 8:117,888,970...117,965,252

G

centromere protein F

multiple interactions

Resveratrol inhibits the reaction [Dietary Fats results in increased expression of CENPF mRNA]

NCBI chr 9:128,948,386...129,012,241
Ensembl chr 9:128,948,498...129,012,218

G

carboxylesterase 3

multiple interactions

[Dietary Fats co-treated with Resveratrol] results in increased expression of CES3 mRNA

NCBI chr 6:27,627,712...27,637,827
Ensembl chr 6:27,627,742...27,638,760

G

CF transmembrane conductance regulator

increases activity

Resveratrol results in increased activity of CFTR protein

NCBI chr18:28,627,717...28,818,209
Ensembl chr18:28,627,728...28,817,950

G

chitinase 3 like 1

multiple interactions

[Dietary Fats co-treated with Resveratrol] results in decreased expression of CHI3L1 mRNA

NCBI chr 9:113,885,541...113,895,033
Ensembl chr 9:113,885,542...113,895,131

G

CAP-Gly domain containing linker protein 1

multiple interactions

[Dietary Fats co-treated with Resveratrol] results in increased expression of CLIP1 mRNA

NCBI chr14:30,320,870...30,467,095
Ensembl chr14:30,320,958...30,467,657

G

clusterin

multiple interactions

Resveratrol promotes the reaction [Dietary Fats results in increased expression of CLU mRNA]

NCBI chr14:11,336,585...11,352,569
Ensembl chr14:11,336,595...11,349,764

G

collagen type XIV alpha 1 chain

multiple interactions

[Dietary Fats co-treated with Resveratrol] results in decreased expression of COL14A1 mRNA

NCBI chr 4:18,690,197...18,925,111
Ensembl chr 4:18,690,198...18,924,971

G

collagen type I alpha 1 chain

multiple interactions

Resveratrol inhibits the reaction [Dietary Fats results in increased expression of COL1A1 mRNA]

NCBI chr12:26,379,087...26,397,180
Ensembl chr12:26,379,090...26,397,004

G

collagen type I alpha 2 chain

multiple interactions

Resveratrol inhibits the reaction [Dietary Fats results in increased expression of COL1A2 mRNA]

NCBI chr 9:74,174,484...74,210,407
Ensembl chr 9:74,173,931...74,210,397

G

collagen type III alpha 1 chain

multiple interactions

Resveratrol inhibits the reaction [Dietary Fats results in increased expression of COL3A1 mRNA]

NCBI chr15:93,556,914...93,595,678
Ensembl chr15:93,526,603...93,596,363

G

cytochrome c oxidase copper chaperone COX11

multiple interactions

[Dietary Fats co-treated with Resveratrol] results in increased expression of COX11 mRNA

NCBI chr12:31,268,397...31,277,850
Ensembl chr12:31,267,520...31,277,429

G

cysteine rich secretory protein LCCL domain containing 2

multiple interactions

[Dietary Fats co-treated with Resveratrol] results in increased expression of CRISPLD2 mRNA

NCBI chr 6:3,881,715...3,944,592
Ensembl chr 6:3,881,725...3,944,583

G

C-reactive protein, pentraxin-related

decreases expression

Resveratrol results in decreased expression of CRP protein

NCBI chr 4:90,793,361...90,801,020
Ensembl chr 4:90,793,350...90,805,218

G

crystallin beta A1

multiple interactions

[Dietary Fats co-treated with Resveratrol] results in increased expression of CRYBA1 mRNA

NCBI chr12:45,466,051...45,473,110
Ensembl chr12:45,466,520...45,473,092

G

catenin alpha 1

multiple interactions

[Dietary Fats co-treated with Resveratrol] results in increased expression of CTNNA1 mRNA

NCBI chr 2:140,682,776...140,869,828
Ensembl chr 2:140,682,371...140,871,334

G

cathepsin V

multiple interactions

Resveratrol inhibits the reaction [Dietary Fats results in increased expression of CTSV mRNA]

NCBI chr10:25,202,360...25,208,058
Ensembl chr10:25,202,389...25,209,210

G

cytochrome b561

multiple interactions

[Dietary Fats co-treated with Resveratrol] results in decreased expression of CYB561 mRNA

NCBI chr12:15,435,973...15,447,104
Ensembl chr12:15,436,803...15,447,100

G

dishevelled binding antagonist of beta catenin 1

multiple interactions

Resveratrol inhibits the reaction [Dietary Fats results in increased expression of DACT1 mRNA]

NCBI chr 1:187,719,391...187,729,568
Ensembl chr 1:187,719,290...187,729,422

G

aspartyl-tRNA synthetase 1

multiple interactions

[Dietary Fats co-treated with Resveratrol] results in decreased expression of DARS1 mRNA

NCBI chr15:15,810,497...15,885,706
Ensembl chr15:15,810,618...15,885,706

G

decorin

multiple interactions

Resveratrol inhibits the reaction [Dietary Fats results in increased expression of DCN mRNA]

NCBI chr 5:91,678,601...91,713,925
Ensembl chr 5:91,682,658...91,714,235

G

DEAD-box helicase 17

multiple interactions

[Dietary Fats co-treated with Resveratrol] results in increased expression of DDX17 mRNA; Resveratrol promotes the reaction [Dietary Fats results in decreased expression of DDX17 mRNA]

NCBI chr 5:9,485,792...9,505,157
Ensembl chr 5:9,485,702...9,505,157

G

Dmx like 2

multiple interactions

Resveratrol inhibits the reaction [Dietary Fats results in increased expression of DMXL2 mRNA]

NCBI chr 1:120,138,249...120,298,603
Ensembl chr 1:120,138,336...120,298,586

G

DnaJ heat shock protein family (Hsp40) member B14

multiple interactions

[Dietary Fats co-treated with Resveratrol] results in decreased expression of DNAJB14 mRNA

NCBI chr 8:120,567,395...120,623,518
Ensembl chr 8:120,567,390...120,623,513

G

destrin, actin depolymerizing factor

multiple interactions

[Dietary Fats co-treated with Resveratrol] results in increased expression of DSTN mRNA

NCBI chr17:25,998,830...26,050,354
Ensembl chr17:26,043,079...26,050,353

G

dynein cytoplasmic 2 heavy chain 1

multiple interactions

[Dietary Fats co-treated with Resveratrol] results in decreased expression of DYNC2H1 mRNA

NCBI chr 9:33,720,920...34,039,954
Ensembl chr 9:33,720,877...34,040,188

G

epithelial cell transforming 2

multiple interactions

Resveratrol inhibits the reaction [Dietary Fats results in increased expression of ECT2 mRNA]

NCBI chr13:111,248,215...111,310,746
Ensembl chr13:111,248,131...111,314,828

G

eukaryotic translation elongation factor 1 alpha 1

multiple interactions

Resveratrol inhibits the reaction [Dietary Fats results in increased expression of EEF1A1 mRNA]

NCBI chr 1:92,421,235...92,425,053
Ensembl chr 1:92,421,230...92,425,044

G

early growth response 1

multiple interactions

Resveratrol inhibits the reaction [Dietary Fats results in increased expression of EGR1 mRNA]

NCBI chr 2:140,440,829...140,445,302
Ensembl chr 2:140,441,421...140,445,296

G

ectonucleotide pyrophosphatase/phosphodiesterase 1

multiple interactions

Resveratrol inhibits the reaction [Dietary Fats results in increased expression of ENPP1 mRNA]

NCBI chr 1:31,724,290...31,796,594
Ensembl chr 1:31,722,721...31,796,595

G

ectonucleoside triphosphate diphosphohydrolase 1

multiple interactions

[Dietary Fats co-treated with Resveratrol] results in increased expression of ENTPD1 mRNA

NCBI chr14:107,263,546...107,390,923
Ensembl chr14:107,263,449...107,389,010

G

epithelial cell adhesion molecule

multiple interactions

Resveratrol inhibits the reaction [Dietary Fats results in increased expression of EPCAM mRNA]

NCBI chr 3:93,169,800...93,185,221
Ensembl chr 3:93,168,852...93,185,653

G

ERBB receptor feedback inhibitor 1

multiple interactions

[Dietary Fats co-treated with Resveratrol] results in decreased expression of ERRFI1 mRNA

NCBI chr 6:68,667,651...68,682,629
Ensembl chr 6:68,669,153...68,682,623

G

ETS variant transcription factor 5

multiple interactions

[Dietary Fats co-treated with Resveratrol] results in decreased expression of ETV5 mRNA

NCBI chr13:123,873,346...123,930,292
Ensembl chr13:123,873,350...123,930,200

G

EYA transcriptional coactivator and phosphatase 3

multiple interactions

[Dietary Fats co-treated with Resveratrol] results in decreased expression of EYA3 mRNA

NCBI chr 6:85,095,409...85,185,856
Ensembl chr 6:85,095,409...85,185,799

G

fatty acid binding protein 4

multiple interactions

Resveratrol inhibits the reaction [Dietary Fats results in increased expression of FABP4 mRNA]

NCBI chr 4:55,096,400...55,101,209
Ensembl chr 4:55,096,404...55,101,896

G

fatty acid binding protein 6

multiple interactions

Resveratrol inhibits the reaction [Dietary Fats results in increased expression of FABP6 mRNA]

NCBI chr16:63,297,594...63,303,675
Ensembl chr16:63,297,595...63,303,697

G

family with sequence similarity 72 member A

multiple interactions

[Dietary Fats co-treated with Resveratrol] results in decreased expression of FAM72A mRNA

NCBI chr 9:66,824,251...66,839,780

G

fibrillin 1

multiple interactions

Resveratrol inhibits the reaction [Dietary Fats results in increased expression of FBN1 mRNA]

NCBI chr 1:123,102,011...123,359,649
Ensembl chr 1:123,102,009...123,359,649

G

F-box protein 5

multiple interactions

[Dietary Fats co-treated with Resveratrol] results in decreased expression of FBXO5 mRNA

NCBI chr 1:13,466,961...13,478,496
Ensembl chr 1:13,467,501...13,505,928

G

Fc epsilon receptor Ia

multiple interactions

[Dietary Fats co-treated with Resveratrol] results in decreased expression of FCER1A mRNA

NCBI chr 4:91,118,867...91,125,448
Ensembl chr 4:91,118,879...91,125,437

G

forkhead box O1

decreases expression

Resveratrol results in decreased expression of FOXO1 mRNA

NCBI chr11:15,317,222...15,410,059
Ensembl chr11:15,317,124...15,410,473

G

follistatin like 1

multiple interactions

Resveratrol inhibits the reaction [Dietary Fats results in increased expression of FSTL1 mRNA]

NCBI chr13:139,847,246...139,901,972
Ensembl chr13:139,847,438...139,901,965

G

growth arrest specific 1

multiple interactions

Resveratrol inhibits the reaction [Dietary Fats results in increased expression of GAS1 mRNA]

NCBI chr10:28,509,168...28,511,554
Ensembl chr10:28,509,261...28,510,301

G

GATA binding protein 3

multiple interactions

Resveratrol inhibits the reaction [Dietary Fats results in decreased expression of GATA3 mRNA]

NCBI chr10:63,367,684...63,397,977
Ensembl chr10:63,367,663...63,388,859

G

gap junction protein alpha 1

multiple interactions

Resveratrol inhibits the reaction [Dietary Fats results in increased expression of GJA1 mRNA]

NCBI chr 1:40,988,818...41,002,129
Ensembl chr 1:40,988,528...41,002,156

G

gap junction protein alpha 10

multiple interactions

[Dietary Fats co-treated with Resveratrol] results in increased expression of GJA10 mRNA

NCBI chr 1:57,879,740...57,881,395
Ensembl chr 1:57,868,387...57,893,687

G

golgi integral membrane protein 4

multiple interactions

[Dietary Fats co-treated with Resveratrol] results in decreased expression of GOLIM4 mRNA; Resveratrol inhibits the reaction [Dietary Fats results in decreased expression of GOLIM4 mRNA]

NCBI chr13:106,814,825...106,895,209
Ensembl chr13:106,814,821...106,895,186

G

glycerol-3-phosphate dehydrogenase 2

multiple interactions

[Dietary Fats co-treated with Resveratrol] results in increased expression of GPD2 mRNA

NCBI chr15:63,592,723...63,728,636
Ensembl chr15:63,619,762...63,728,633

G

H2A.X variant histone

multiple interactions

Resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of H2AX protein]

NCBI chr 9:46,308,824...46,310,494
Ensembl chr 9:46,309,653...46,310,084

G

heparin binding EGF like growth factor

multiple interactions

[Dietary Fats co-treated with Resveratrol] results in increased expression of DTR mRNA

NCBI chr 2:142,102,455...142,115,192
Ensembl chr 2:142,102,458...142,115,174

G

heterogeneous nuclear ribonucleoprotein L like

multiple interactions

Resveratrol inhibits the reaction [Dietary Fats results in increased expression of HNRNPLL mRNA]

NCBI chr 3:101,753,330...101,795,356
Ensembl chr 3:101,753,292...101,802,062

G

hydroxysteroid 17-beta dehydrogenase 12

multiple interactions

Resveratrol inhibits the reaction [Dietary Fats results in increased expression of HSD17B12 mRNA]

NCBI chr 2:18,461,487...18,611,761
Ensembl chr 2:18,456,019...18,611,782

G

heat shock protein family A (Hsp70) member 2

multiple interactions

[Dietary Fats co-treated with Resveratrol] results in decreased expression of HSPA2 mRNA

NCBI chr 7:88,607,140...88,609,947

G

isocitrate dehydrogenase (NADP(+)) 2

multiple interactions

[Dietary Fats co-treated with Resveratrol] results in decreased expression of IDH2 mRNA

NCBI chr 7:55,654,298...55,675,571
Ensembl chr 7:55,651,609...55,675,554

G

insulin like growth factor binding protein 5

multiple interactions

[Dietary Fats co-treated with Resveratrol] results in decreased expression of IGFBP5 mRNA

NCBI chr15:118,861,816...118,877,787
Ensembl chr15:118,857,625...118,878,120

G

inhibin subunit beta A

multiple interactions

Resveratrol inhibits the reaction [Dietary Fats results in increased expression of INHBA mRNA]

NCBI chr12:53,115,379...53,117,128
NCBI chr18:52,889,684...52,909,260
Ensembl chr18:52,889,684...52,900,967

G

interaction protein for cytohesin exchange factors 1

multiple interactions

[Dietary Fats co-treated with Resveratrol] results in increased expression of IPCEF1 mRNA

NCBI chr 1:12,511,612...12,602,736
Ensembl chr 1:12,506,220...12,602,724

G

insulin receptor substrate 1

increases expression

Resveratrol results in increased expression of IRS1 protein

PMID:21575630 PMID:21739664

NCBI chr15:128,245,846...128,307,321
Ensembl chr15:128,245,846...128,307,284

G

integrin subunit alpha 2

multiple interactions

Resveratrol inhibits the reaction [Dietary Fats results in decreased expression of ITGA2 mRNA]

NCBI chr16:32,336,240...32,440,311
Ensembl chr16:32,336,292...32,437,103

G

integrin subunit alpha V

multiple interactions

Resveratrol inhibits the reaction [Dietary Fats results in increased expression of ITGAV mRNA]

NCBI chr15:91,604,666...91,711,843
Ensembl chr15:91,604,676...91,711,851

G

potassium voltage-gated channel subfamily H member 8

multiple interactions

Resveratrol inhibits the reaction [Dietary Fats results in increased expression of KCNH8 mRNA]

NCBI chr13:6,104,382...6,533,505
Ensembl chr13:6,104,537...6,532,592

G

kinesin family member 11

multiple interactions

Resveratrol inhibits the reaction [Dietary Fats results in increased expression of KIF11 mRNA]

NCBI chr14:104,125,839...104,177,381
Ensembl chr14:104,125,898...104,177,379

G

kinesin family member 15

multiple interactions

Resveratrol inhibits the reaction [Dietary Fats results in increased expression of KIF15 mRNA]

NCBI chr13:27,966,586...28,041,121
Ensembl chr13:27,966,586...28,041,451

G

kinesin family member 7

multiple interactions

[Dietary Fats co-treated with Resveratrol] results in increased expression of KIF7 mRNA

NCBI chr 7:55,200,591...55,220,237
Ensembl chr 7:55,200,594...55,220,240

G

kynurenine 3-monooxygenase

multiple interactions

Resveratrol inhibits the reaction [Dietary Fats results in decreased expression of KMO mRNA]

NCBI chr10:12,442,877...12,489,417
Ensembl chr10:12,434,769...12,490,409

G

LIF interleukin 6 family cytokine

multiple interactions

Resveratrol inhibits the reaction [Dietary Fats results in increased expression of LIF mRNA]

NCBI chr14:47,221,540...47,239,513
Ensembl chr14:47,221,560...47,238,749

G

lunapark, ER junction formation factor

multiple interactions

[Dietary Fats co-treated with Resveratrol] results in increased expression of LNPK mRNA

NCBI chr15:81,721,637...81,805,706
Ensembl chr15:81,721,644...81,805,680

G

phosphatidylinositol 3-kinase regulatory subunit gamma

multiple interactions

[Dietary Fats co-treated with Resveratrol] results in decreased expression of PIK3R3 mRNA

NCBI chr 6:165,268,260...165,402,668
Ensembl chr 6:165,268,568...165,402,649

G

uncharacterized LOC102158035

multiple interactions

Resveratrol inhibits the reaction [Dietary Fats results in increased expression of TRAC mRNA]

NCBI chr 7:76,471,215...77,056,010

G

lipoprotein lipase

multiple interactions

Resveratrol inhibits the reaction [Dietary Fats results in increased expression of LPL mRNA]

NCBI chr14:4,104,761...4,134,964
Ensembl chr14:4,104,772...4,135,814

G

limbic system associated membrane protein

multiple interactions

Resveratrol inhibits the reaction [Dietary Fats results in increased expression of LSAMP mRNA]

NCBI chr13:143,675,521...144,304,186
Ensembl chr13:143,675,575...144,304,151

G

MAM domain containing 2

multiple interactions

[Dietary Fats co-treated with Resveratrol] results in decreased expression of MAMDC2 mRNA

NCBI chr 1:223,541,491...223,547,723
Ensembl chr 1:223,384,827...223,548,420

G

mitogen-activated protein kinase 1

multiple interactions

Resveratrol results in decreased phosphorylation of and results in decreased activity of MAPK1 protein

NCBI chr14:50,083,079...50,165,528
Ensembl chr14:50,082,896...50,165,513

G

mitogen-activated protein kinase 3

multiple interactions

Resveratrol results in decreased phosphorylation of and results in decreased activity of MAPK3 protein

NCBI chr 3:18,291,444...18,299,410
Ensembl chr 3:18,291,445...18,299,567

G

mitogen-activated protein kinase 8

multiple interactions

Resveratrol results in decreased phosphorylation of and results in decreased activity of MAPK8 protein

NCBI chr14:88,988,914...89,108,875
Ensembl chr14:88,988,949...89,108,874

G

MARCKS like 1

multiple interactions

[Dietary Fats co-treated with Resveratrol] results in decreased expression of MARCKSL1 mRNA

NCBI chr 6:88,785,412...88,787,772
Ensembl chr 6:88,786,175...88,787,766

G

membrane bound transcription factor peptidase, site 1

multiple interactions

[Dietary Fats co-treated with Resveratrol] results in increased expression of MBTPS1 mRNA

NCBI chr 6:4,503,530...4,558,601
Ensembl chr 6:4,503,565...4,558,609

G

mesenteric estrogen dependent adipogenesis

multiple interactions

Resveratrol inhibits the reaction [Dietary Fats results in increased expression of MEDAG mRNA]

NCBI chr11:7,545,400...7,562,741
Ensembl chr11:7,545,494...7,562,737

G

microfibril associated protein 5

multiple interactions

[Dietary Fats co-treated with Resveratrol] results in decreased expression of MFAP5 mRNA

NCBI chr 5:62,742,520...62,757,522
Ensembl chr 5:62,742,319...62,757,519

G

monocyte to macrophage differentiation associated 2

multiple interactions

Resveratrol inhibits the reaction [Dietary Fats results in increased expression of MMD2 mRNA]

NCBI chr 3:3,728,126...3,782,605
Ensembl chr 3:3,729,531...3,775,205

G

matrix metallopeptidase 13

decreases expression
decreases activity

Resveratrol results in decreased expression of MMP13 mRNA
Resveratrol results in decreased activity of MMP13 protein

NCBI chr 9:33,549,003...33,616,700
Ensembl chr 9:33,549,008...33,561,162

G

matrix metallopeptidase 2

multiple interactions

Resveratrol inhibits the reaction [Tobacco Smoke Pollution results in increased activity of MMP2 protein]

NCBI chr 6:30,059,247...30,087,031
Ensembl chr 6:30,058,595...30,086,982

G

myelin protein zero like 2

multiple interactions

Resveratrol inhibits the reaction [Dietary Fats results in increased expression of MPZL2 mRNA]

NCBI chr 9:45,566,365...45,578,168
Ensembl chr 9:45,565,513...45,578,185

G

musashi RNA binding protein 2

multiple interactions

Resveratrol inhibits the reaction [Dietary Fats results in increased expression of MSI2 mRNA]

NCBI chr12:33,537,163...33,974,845
Ensembl chr12:33,537,196...33,975,548

G

mechanistic target of rapamycin kinase

increases expression

Resveratrol results in increased expression of MTOR protein

NCBI chr 6:71,286,989...71,412,913
Ensembl chr 6:71,286,989...71,412,888

G

MYCN proto-oncogene, bHLH transcription factor

multiple interactions

Resveratrol inhibits the reaction [Dietary Fats results in increased expression of MYCN mRNA]

NCBI chr 3:121,543,201...121,549,678
Ensembl chr 3:121,543,109...121,549,046

G

myosin heavy chain 10

multiple interactions

Resveratrol inhibits the reaction [Dietary Fats results in increased expression of MYH10 mRNA]

NCBI chr12:53,647,579...53,781,552

G

myosin light chain kinase

multiple interactions

[Dietary Fats co-treated with Resveratrol] results in increased expression of MYLK mRNA

NCBI chr13:136,509,878...136,809,674
Ensembl chr13:136,509,755...136,809,668

G

myosin X

multiple interactions

[Dietary Fats co-treated with Resveratrol] results in decreased expression of MYO10 mRNA

NCBI chr16:5,907,111...6,145,485
Ensembl chr16:5,907,116...6,094,845

G

neurobeachin

multiple interactions

[Dietary Fats co-treated with Resveratrol] results in increased expression of NBEA mRNA

NCBI chr11:11,085,081...11,722,859
Ensembl chr11:11,084,992...11,722,847

G

NDC80 kinetochore complex component

multiple interactions

Resveratrol inhibits the reaction [Dietary Fats results in increased expression of NDC80 mRNA]

NCBI chr 6:104,000,794...104,055,785
Ensembl chr 6:103,999,034...104,055,760

G

NIMA related kinase 2

multiple interactions

[Dietary Fats co-treated with Resveratrol] results in decreased expression of NEK2 mRNA

NCBI chr 9:131,547,044...131,560,527
Ensembl chr 9:131,547,069...131,561,095

G

NFKB inhibitor alpha

decreases degradation

Resveratrol results in decreased degradation of NFKBIA protein

NCBI chr 7:64,508,119...64,510,754
Ensembl chr 7:64,507,822...64,511,277

G

nitric oxide synthase 2

decreases expression
multiple interactions

Resveratrol results in decreased expression of NOS2 protein
Resveratrol inhibits the reaction [NOS2 protein results in increased chemical synthesis of Nitric Oxide]

NCBI chr12:44,174,944...44,219,875
Ensembl chr12:44,174,948...44,218,146

G

protegrin 4

multiple interactions

Resveratrol inhibits the reaction [Dietary Fats results in increased expression of CAMP mRNA]

NCBI chr13:30,932,411...30,934,626
Ensembl chr13:30,932,232...30,987,873

G

NAD(P)H quinone dehydrogenase 1

multiple interactions

[Dietary Fats co-treated with Resveratrol] results in increased expression of NQO1 mRNA

NCBI chr 6:17,292,962...17,302,593
Ensembl chr 6:17,292,770...17,302,590

G

neuronal regeneration related protein

multiple interactions

Resveratrol inhibits the reaction [Dietary Fats results in increased expression of NREP mRNA]

NCBI chr 2:117,505,851...117,867,805
Ensembl chr 2:117,838,660...117,867,801

G

NUF2 component of NDC80 kinetochore complex

multiple interactions

Resveratrol inhibits the reaction [Dietary Fats results in increased expression of NUF2 mRNA]

NCBI chr 4:87,162,873...87,194,193
Ensembl chr 4:87,162,818...87,194,170

G

nucleolar and spindle associated protein 1

multiple interactions

Resveratrol inhibits the reaction [Dietary Fats results in increased expression of NUSAP1 mRNA]

NCBI chr 1:129,992,797...130,065,641
Ensembl chr 1:129,992,804...130,065,605

G

purinergic receptor P2Y12

multiple interactions

[Dietary Fats co-treated with Resveratrol] results in increased expression of P2RY12 mRNA

NCBI chr13:91,522,754...91,572,195
Ensembl chr13:91,521,817...91,572,005

G

p21 (RAC1) activated kinase 3

multiple interactions

[Dietary Fats co-treated with Resveratrol] results in increased expression of PAK3 mRNA

NCBI chr X:90,941,976...91,244,331
Ensembl chr X:90,942,077...91,238,565

G

PALM2-AKAP2 fusion

multiple interactions

Resveratrol inhibits the reaction [Dietary Fats results in increased expression of PALM2AKAP2 mRNA]

NCBI chr 1:250,824,055...250,968,545
NCBI chr 1:250,984,658...251,190,244
Ensembl chr 1:250,680,942...251,190,244

G

3'-phosphoadenosine 5'-phosphosulfate synthase 1

multiple interactions

[Dietary Fats co-treated with Resveratrol] results in increased expression of PAPSS1 mRNA

NCBI chr 8:114,252,059...114,369,309
Ensembl chr 8:114,252,416...114,373,427

G

parvin beta

multiple interactions

Resveratrol inhibits the reaction [Dietary Fats results in decreased expression of PARVB mRNA]

NCBI chr 5:4,906,667...5,015,494
Ensembl chr 5:4,906,685...5,015,441

G

PDZ binding kinase

multiple interactions

Resveratrol inhibits the reaction [Dietary Fats results in increased expression of PBK mRNA]

NCBI chr14:11,543,657...11,577,286
Ensembl chr14:11,543,603...11,566,702

G

PCNA clamp associated factor

multiple interactions

[Dietary Fats co-treated with Resveratrol] results in decreased expression of PCLAF mRNA

NCBI chr 1:107,659,509...107,669,477
Ensembl chr 1:107,659,509...107,670,954

G

phosphodiesterase 4D

multiple interactions

[Dietary Fats co-treated with Resveratrol] results in increased expression of PDE4D mRNA

NCBI chr16:37,897,300...39,406,534
Ensembl chr16:37,897,302...39,306,364

G

PDZ domain containing 2

multiple interactions

Resveratrol inhibits the reaction [Dietary Fats results in increased expression of PDZD2 mRNA]

NCBI chr16:17,940,113...18,355,540

G

paternally expressed 3

multiple interactions

[Dietary Fats co-treated with Resveratrol] results in increased expression of PEG3 mRNA

NCBI chr 6:61,281,931...61,307,788
Ensembl chr 6:61,285,456...61,292,885

G

phosphotyrosine interaction domain containing 1

multiple interactions

[Dietary Fats co-treated with Resveratrol] results in increased expression of PID1 mRNA

NCBI chr15:130,080,821...130,215,548
Ensembl chr15:130,075,143...130,332,698

G

piwi like RNA-mediated gene silencing 3

multiple interactions

[Dietary Fats co-treated with Resveratrol] results in decreased expression of PIWIL3 mRNA

NCBI chr14:42,834,819...42,869,486
Ensembl chr14:42,835,302...42,869,566

G

polo like kinase 4

multiple interactions

Resveratrol inhibits the reaction [Dietary Fats results in increased expression of PLK4 mRNA]

NCBI chr 8:96,989,011...97,013,324
Ensembl chr 8:96,991,847...97,013,461

G

peroxisome proliferator activated receptor alpha

multiple interactions

Resveratrol inhibits the reaction [Dietary Fats results in decreased expression of PPARA protein]

NCBI chr 5:3,302,755...3,321,091
Ensembl chr 5:3,300,741...3,364,239

G

peroxisome proliferator activated receptor gamma

decreases expression
multiple interactions

Resveratrol results in decreased expression of PPARG mRNA; Resveratrol results in decreased expression of PPARG protein
Resveratrol inhibits the reaction [Dietary Fats results in decreased expression of PPARG protein]

PMID:17851734 PMID:21575630 PMID:21739664

NCBI chr13:68,301,566...68,433,951
Ensembl chr13:68,302,322...68,433,944

G

PPARG coactivator 1 alpha

increases expression

Resveratrol results in increased expression of PPARGC1A protein

NCBI chr 8:17,841,844...18,527,953
Ensembl chr 8:17,841,844...17,946,992

G

phosphoribosyl pyrophosphate amidotransferase

multiple interactions

Resveratrol inhibits the reaction [Dietary Fats results in increased expression of PPAT mRNA]

NCBI chr 8:55,652,194...55,701,077
Ensembl chr 8:55,654,377...55,701,077

G

pro-platelet basic protein

multiple interactions

[Dietary Fats co-treated with Resveratrol] results in increased expression of PPBP mRNA

NCBI chr 8:70,021,468...70,022,490
Ensembl chr 8:70,021,439...70,023,964

G

protein phosphatase 1 regulatory subunit 3B

multiple interactions

[Dietary Fats co-treated with Resveratrol] results in increased expression of PPP1R3B mRNA

NCBI chr15:56,002,383...56,013,477
Ensembl chr15:56,002,378...56,013,478

G

protein S

multiple interactions

[Dietary Fats co-treated with Resveratrol] results in increased expression of PROS1 mRNA

NCBI chr13:165,915,298...165,999,118
Ensembl chr13:165,911,366...165,999,811

G

serine protease 16

multiple interactions

Resveratrol inhibits the reaction [Dietary Fats results in increased expression of PRSS16 mRNA]

NCBI chr 7:21,276,997...21,285,314
Ensembl chr 7:21,276,965...21,285,311

G

phosphoserine aminotransferase 1

multiple interactions

Resveratrol inhibits the reaction [Dietary Fats results in increased expression of PSAT1 mRNA]

NCBI chr 1:231,142,673...231,172,364
Ensembl chr 1:231,142,625...231,172,360

G

patched domain containing 4

multiple interactions

[Dietary Fats co-treated with Resveratrol] results in decreased expression of PTCHD4 mRNA

NCBI chr 7:42,570,100...42,770,035
Ensembl chr 7:42,570,094...42,770,225

G

prostaglandin-endoperoxide synthase 2

multiple interactions
decreases expression

[Dietary Fats co-treated with Resveratrol] results in decreased expression of PTGS2 mRNA; Resveratrol inhibits the reaction [PTGS2 protein results in increased chemical synthesis of Dinoprostone]
Resveratrol results in decreased expression of PTGS2 protein

PMID:20825639 PMID:21852083

NCBI chr 9:127,850,164...127,858,866
Ensembl chr 9:127,850,015...127,858,884

G

protein tyrosine phosphatase receptor type R

multiple interactions

Resveratrol inhibits the reaction [Dietary Fats results in increased expression of PTPRR mRNA]

NCBI chr 5:34,794,970...35,048,550
Ensembl chr 5:34,794,977...35,047,818

G

RAB27B, member RAS oncogene family

multiple interactions

[Dietary Fats co-treated with Resveratrol] results in increased expression of RAB27B mRNA

NCBI chr 1:104,241,500...104,418,721
Ensembl chr 1:104,241,571...104,417,084

G

RAB38, member RAS oncogene family

multiple interactions

[Dietary Fats co-treated with Resveratrol] results in increased expression of RAB38 mRNA

NCBI chr 9:21,577,083...21,640,637
Ensembl chr 9:21,577,033...21,640,115

G

retinoic acid receptor responder 1

multiple interactions

[Dietary Fats co-treated with Resveratrol] results in decreased expression of RARRES1 mRNA

NCBI chr13:98,461,307...98,506,552
Ensembl chr13:98,461,320...98,506,173

G

retinol binding protein 4

decreases expression
multiple interactions

Resveratrol results in decreased expression of RBP4 protein
Resveratrol inhibits the reaction [Dietary Fats results in increased expression of RBP4 protein]

PMID:21575630 PMID:21739664

NCBI chr14:105,037,360...105,044,552
Ensembl chr14:105,037,464...105,044,765

G

regulator of calcineurin 1

multiple interactions

[Dietary Fats co-treated with Resveratrol] results in decreased expression of RCAN1 mRNA

NCBI chr13:198,106,256...198,205,727
Ensembl chr13:198,102,098...198,205,629

G

receptor accessory protein 5

multiple interactions

[Dietary Fats co-treated with Resveratrol] results in decreased expression of REEP5 mRNA

NCBI chr 2:116,845,681...116,886,361
Ensembl chr 2:116,845,571...116,886,358

G

ras homolog family member U

multiple interactions

[Dietary Fats co-treated with Resveratrol] results in increased expression of RHOU mRNA

NCBI chr14:60,667,104...60,677,582
Ensembl chr14:60,667,108...60,677,731

G

RHO family interacting cell polarization regulator 2

multiple interactions

[Dietary Fats co-treated with Resveratrol] results in decreased expression of RIPOR2 mRNA

NCBI chr 7:19,609,358...19,842,345
Ensembl chr 7:19,609,358...19,838,093

G

ring finger protein 113A

multiple interactions

Resveratrol inhibits the reaction [Dietary Fats results in increased expression of RNF113A mRNA]

NCBI chr X:98,218,689...98,219,931
Ensembl chr X:98,218,565...98,219,773

G

ring finger protein 128

multiple interactions

Resveratrol inhibits the reaction [Dietary Fats results in increased expression of RNF128 mRNA]

NCBI chr X:87,111,875...87,211,605
Ensembl chr X:87,111,870...87,211,601

G

ribosomal protein L17

multiple interactions

[Dietary Fats co-treated with Resveratrol] results in decreased expression of RPL17 mRNA

NCBI chr 1:99,044,511...99,048,406
Ensembl chr 1:99,043,219...99,048,410

G

ribosomal protein L32

multiple interactions

[Dietary Fats co-treated with Resveratrol] results in decreased expression of RPL32 mRNA

NCBI chr13:68,788,109...68,793,265
Ensembl chr13:68,786,856...68,793,204

G

ribosomal protein L6

multiple interactions

[Dietary Fats co-treated with Resveratrol] results in decreased expression of RPL6 mRNA

NCBI chr14:39,302,447...39,309,239
Ensembl chr14:39,303,350...39,309,236

G

SET binding factor 2

multiple interactions

[Dietary Fats co-treated with Resveratrol] results in increased expression of SBF2 mRNA

NCBI chr 2:49,242,739...49,691,807
Ensembl chr 2:49,242,734...49,698,478

G

Scm polycomb group protein like 2

multiple interactions

[Dietary Fats co-treated with Resveratrol] results in decreased expression of SCML2 mRNA

NCBI chr X:14,715,357...14,823,016
Ensembl chr X:14,717,606...14,823,413

G

serine carboxypeptidase 1

multiple interactions

[Dietary Fats co-treated with Resveratrol] results in increased expression of SCPEP1 mRNA

NCBI chr12:33,265,509...33,296,805
Ensembl chr12:33,265,562...33,298,142

G

serine dehydratase

multiple interactions

[Dietary Fats co-treated with Resveratrol] results in increased expression of SDS mRNA

NCBI chr14:38,503,922...38,513,908
Ensembl chr14:38,503,933...38,513,878

G

selectin P

multiple interactions

[Dietary Fats co-treated with Resveratrol] results in increased expression of SELP mRNA

NCBI chr 4:81,376,804...81,401,240
Ensembl chr 4:81,365,740...81,399,955

G

serine hydrolase like 2

multiple interactions

[Dietary Fats co-treated with Resveratrol] results in decreased expression of SERHL mRNA

NCBI chr 5:6,216,323...6,239,811
Ensembl chr 5:6,216,326...6,230,367

G

serpin family B member 2

multiple interactions

[Dietary Fats co-treated with Resveratrol] results in increased expression of SERPINB2 mRNA

NCBI chr 1:157,871,919...157,886,525
Ensembl chr 1:157,872,212...157,886,602

G

serpin family E member 1

multiple interactions

[Dietary Fats co-treated with Resveratrol] results in increased expression of SERPINE1 mRNA

NCBI chr 3:8,863,738...8,871,572
Ensembl chr 3:8,863,695...8,871,547

G

splicing factor 1

multiple interactions

[Dietary Fats co-treated with Resveratrol] results in increased expression of SF1 mRNA

NCBI chr 2:7,391,295...7,404,693
Ensembl chr 2:7,391,383...7,404,948

G

SH3 domain binding glutamate rich protein like

multiple interactions

[Dietary Fats co-treated with Resveratrol] results in decreased expression of SH3BGRL mRNA

NCBI chr X:64,617,350...64,709,006

G

SH3 domain binding glutamate rich protein like 2

multiple interactions

[Dietary Fats co-treated with Resveratrol] results in increased expression of SH3BGRL2 mRNA

NCBI chr 1:86,416,281...86,481,805
Ensembl chr 1:86,358,483...86,481,776

G

shieldin complex subunit 2

multiple interactions

[Dietary Fats co-treated with Resveratrol] results in increased expression of SHLD2 mRNA

NCBI chr14:88,005,599...88,121,155
Ensembl chr14:88,005,611...88,121,352

G

serine hydroxymethyltransferase 1

multiple interactions

Resveratrol inhibits the reaction [Dietary Fats results in increased expression of SHMT1 mRNA]

NCBI chr12:60,414,421...60,435,451
Ensembl chr12:60,416,463...60,435,450

G

sirtuin 1

increases expression
multiple interactions

Resveratrol results in increased expression of SIRT1 mRNA; Resveratrol results in increased expression of SIRT1 protein
6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide inhibits the reaction [Resveratrol inhibits the reaction [Lipopolysaccharides results in decreased expression of SIRT1 protein]]; Resveratrol inhibits the reaction [Lipopolysaccharides results in decreased expression of SIRT1 protein]

PMID:17037214 PMID:17851734 PMID:23065251 PMID:36549457

NCBI chr14:71,091,167...71,126,351
Ensembl chr14:71,091,167...71,123,297

G

MHC class I antigen 3

multiple interactions

[Dietary Fats co-treated with Resveratrol] results in decreased expression of HLA-A mRNA

NCBI chr 7:22,938,211...22,942,735

G

MHC class I antigen 7

multiple interactions

[Dietary Fats co-treated with Resveratrol] results in decreased expression of HLA-B mRNA; Resveratrol inhibits the reaction [Dietary Fats results in decreased expression of HLA-B mRNA]

NCBI chr 7:23,634,731...23,638,722

G

solute carrier family 20 member 1

multiple interactions

[Dietary Fats co-treated with Resveratrol] results in decreased expression of SLC20A1 mRNA

NCBI chr 3:43,844,716...43,860,547
Ensembl chr 3:43,844,722...43,860,547

G

solute carrier family 24 member 5

multiple interactions

Resveratrol inhibits the reaction [Dietary Fats results in increased expression of SLC24A5 mRNA]

NCBI chr 1:123,635,077...123,657,205
Ensembl chr 1:123,635,043...123,656,736

G

solute carrier family 2 member 1

increases expression

Resveratrol results in increased expression of SLC2A1 protein

NCBI chr 6:168,535,398...168,561,170
Ensembl chr 6:168,535,440...168,560,867

G

solute carrier family 2 member 4

increases expression
multiple interactions

Resveratrol results in increased expression of SLC2A4 protein
Resveratrol inhibits the reaction [Dietary Fats results in decreased expression of SLC2A4 protein]

PMID:21575630 PMID:21739664

NCBI chr12:52,628,746...52,634,965
Ensembl chr12:52,628,450...52,634,967

G

solute carrier family 40 member 1

multiple interactions

[Dietary Fats co-treated with Resveratrol] results in increased expression of SLC40A1 mRNA

NCBI chr15:94,140,635...94,161,793
Ensembl chr15:94,141,988...94,167,408

G

solute carrier family 4 member 4

multiple interactions

Resveratrol inhibits the reaction [Dietary Fats results in increased expression of SLC4A4 mRNA]

NCBI chr 8:67,768,955...68,177,213
Ensembl chr 8:67,706,874...68,177,212

G

superoxide dismutase 1

multiple interactions

Resveratrol inhibits the reaction [Lipopolysaccharides results in decreased expression of SOD1 mRNA]

NCBI chr13:195,326,573...195,335,273
Ensembl chr13:195,326,649...195,337,729

G

SRY-box transcription factor 13

multiple interactions

[Dietary Fats co-treated with Resveratrol] results in decreased expression of SOX13 mRNA

NCBI chr 9:64,745,762...64,780,942
Ensembl chr 9:64,731,969...64,780,942

G

SRY-box transcription factor 4

multiple interactions

[Dietary Fats co-treated with Resveratrol] results in decreased expression of SOX4 mRNA

NCBI chr 7:16,886,834...16,895,488
Ensembl chr 7:16,891,319...16,892,752

G

secreted protein acidic and cysteine rich

multiple interactions

Resveratrol inhibits the reaction [Dietary Fats results in increased expression of SPARC mRNA]

NCBI chr16:71,368,164...71,380,972
Ensembl chr16:71,357,586...71,381,161

G

SPC25 component of NDC80 kinetochore complex

multiple interactions

[Dietary Fats co-treated with Resveratrol] results in decreased expression of SPC25 mRNA

NCBI chr15:75,339,171...75,371,275
Ensembl chr15:75,336,514...75,371,277

G

spen family transcriptional repressor

multiple interactions

[Dietary Fats co-treated with Resveratrol] results in increased expression of SPEN mRNA

NCBI chr 6:75,015,565...75,107,468
Ensembl chr 6:75,015,521...75,107,033

G

secreted phosphoprotein 1

multiple interactions

[Dietary Fats co-treated with Resveratrol] results in decreased expression of SPP1 mRNA

NCBI chr 8:131,077,786...131,085,334
Ensembl chr 8:131,077,786...131,085,340

G

SSX family member 2 interacting protein

multiple interactions

[Dietary Fats co-treated with Resveratrol] results in increased expression of SSX2IP mRNA

NCBI chr 6:129,049,186...129,113,622
Ensembl chr 6:129,055,523...129,114,217

G

syntaxin 8

multiple interactions

Resveratrol inhibits the reaction [Dietary Fats results in increased expression of STX8 mRNA]

NCBI chr12:54,296,988...54,544,668
Ensembl chr12:54,296,995...54,544,646

G

synaptotagmin like 4

multiple interactions

[Dietary Fats co-treated with Resveratrol] results in increased expression of SYTL4 mRNA

NCBI chr X:82,367,546...82,437,439
Ensembl chr X:82,367,549...82,437,401

G

transgelin 2

multiple interactions

Resveratrol inhibits the reaction [Dietary Fats results in increased expression of TAGLN2 mRNA]

NCBI chr 4:90,566,272...90,574,762

G

tissue factor pathway inhibitor

multiple interactions

[Dietary Fats co-treated with Resveratrol] results in increased expression of TFPI mRNA

NCBI chr15:92,345,083...92,409,962
Ensembl chr15:92,345,075...92,409,905

G

transforming growth factor beta 2

multiple interactions

[Dietary Fats co-treated with Resveratrol] results in increased expression of TGFB2 mRNA

NCBI chr10:8,306,136...8,435,307
Ensembl chr10:8,305,539...8,390,341

G

thyroid hormone receptor associated protein 3

multiple interactions

[Dietary Fats co-treated with Resveratrol] results in increased expression of THRAP3 mRNA

NCBI chr 6:92,350,021...92,412,335
Ensembl chr 6:92,355,667...92,412,330

G

TIMP metallopeptidase inhibitor 3

multiple interactions

Resveratrol inhibits the reaction [Dietary Fats results in increased expression of TIMP3 mRNA]

NCBI chr 5:12,185,816...12,242,599
Ensembl chr 5:12,185,818...12,242,581

G

transmembrane p24 trafficking protein 4

multiple interactions

[Dietary Fats co-treated with Resveratrol] results in increased expression of TMED4 mRNA

NCBI chr18:50,698,819...50,702,333
Ensembl chr18:50,699,470...50,702,705

G

transmembrane protein 117

multiple interactions

[Dietary Fats co-treated with Resveratrol] results in increased expression of TMEM117 mRNA

NCBI chr 5:74,917,081...75,402,839
Ensembl chr 5:74,917,463...75,406,367

G

transmembrane protein 40

multiple interactions

[Dietary Fats co-treated with Resveratrol] results in increased expression of TMEM40 mRNA

NCBI chr13:68,705,606...68,737,194
Ensembl chr13:68,692,120...68,758,651

G

transmembrane protein 47

multiple interactions

[Dietary Fats co-treated with Resveratrol] results in increased expression of TMEM47 mRNA

NCBI chr X:30,584,044...30,615,233
Ensembl chr X:30,584,046...30,615,232

G

thymosin beta 10

multiple interactions

[Dietary Fats co-treated with Resveratrol] results in decreased expression of TMSB10 mRNA

NCBI chr 3:59,776,236...59,777,252
Ensembl chr 3:59,776,236...59,777,252

G

DNA topoisomerase II alpha

multiple interactions

[Dietary Fats co-treated with Resveratrol] results in decreased expression of TOP2A mRNA

NCBI chr12:22,001,300...22,028,452
Ensembl chr12:22,001,282...22,028,450

G

tumor protein p53

multiple interactions

Resveratrol results in increased expression of and results in increased acetylation of TP53 protein

NCBI chr12:52,939,643...52,953,786
Ensembl chr12:52,939,644...52,953,818

G

TPX2 microtubule nucleation factor

multiple interactions

[Dietary Fats co-treated with Resveratrol] results in decreased expression of TPX2 mRNA

NCBI chr17:35,431,271...35,484,814
Ensembl chr17:35,431,395...35,485,065

G

tripartite motif containing 13

multiple interactions

Resveratrol inhibits the reaction [Dietary Fats results in increased expression of TRIM13 mRNA]

NCBI chr11:17,785,031...17,850,005
Ensembl chr11:17,793,784...17,849,732

G

TSC22 domain family member 2

multiple interactions

[Dietary Fats co-treated with Resveratrol] results in decreased expression of TSC22D2 mRNA

NCBI chr13:90,640,490...90,697,671
Ensembl chr13:90,641,175...90,691,568

G

ubiquitin conjugating enzyme E2 C

multiple interactions

[Dietary Fats co-treated with Resveratrol] results in decreased expression of UBE2C mRNA

NCBI chr17:48,018,403...48,021,542
Ensembl chr17:48,018,400...48,021,534

G

ubiquitin conjugating enzyme E2 U

multiple interactions

[Dietary Fats co-treated with Resveratrol] results in increased expression of UBE2U mRNA

NCBI chr 6:148,233,498...148,314,193
Ensembl chr 6:148,233,412...148,305,330

G

UDP-glucuronosyltransferase 2B31

multiple interactions

[Dietary Fats co-treated with Resveratrol] results in increased expression of UGT2B11 mRNA

NCBI chr 8:66,310,697...66,323,755
Ensembl chr 8:66,308,581...66,324,051

G

ubiquitin like with PHD and ring finger domains 1

multiple interactions

Resveratrol inhibits the reaction [Dietary Fats results in increased expression of UHRF1 mRNA]

NCBI chr 2:73,898,061...73,937,727
Ensembl chr 2:73,898,071...73,931,769

G

usherin

multiple interactions

[Dietary Fats co-treated with Resveratrol] results in increased expression of USH2A mRNA

NCBI chr10:5,825,591...6,662,733

G

vav guanine nucleotide exchange factor 3

multiple interactions

[Dietary Fats co-treated with Resveratrol] results in decreased expression of VAV3 mRNA

NCBI chr 4:111,825,071...112,202,833
Ensembl chr 4:111,824,896...112,202,825

G

WEE1 G2 checkpoint kinase

multiple interactions

[Dietary Fats co-treated with Resveratrol] results in decreased expression of WEE1 mRNA

NCBI chr 2:49,880,416...49,894,509
Ensembl chr 2:49,880,435...49,894,499

G

zinc finger DHHC-type palmitoyltransferase 2

multiple interactions

Resveratrol promotes the reaction [Dietary Fats results in increased expression of ZDHHC2 mRNA]

NCBI chr17:4,855,129...4,928,109
Ensembl chr17:4,855,345...4,928,664

G

zinc finger protein 462

multiple interactions

[Dietary Fats co-treated with Resveratrol] results in decreased expression of ZNF462 mRNA

NCBI chr 1:248,029,136...248,181,792
Ensembl chr 1:248,031,631...248,179,784

G

zinc finger protein 507

multiple interactions

Resveratrol inhibits the reaction [Dietary Fats results in increased expression of ZNF507 mRNA]

NCBI chr 6:42,274,192...42,316,764
Ensembl chr 6:42,274,206...42,316,755

sarpogrelate

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

Fos proto-oncogene, AP-1 transcription factor subunit

multiple interactions

sarpogrelate inhibits the reaction [Serotonin results in increased expression of FOS mRNA]; sarpogrelate inhibits the reaction [Serotonin results in increased expression of FOS protein]

NCBI chr 7:98,449,508...98,451,971
Ensembl chr 7:98,449,349...98,455,554

G

Jun proto-oncogene, AP-1 transcription factor subunit

multiple interactions

sarpogrelate inhibits the reaction [Serotonin results in increased expression of JUN mRNA]; sarpogrelate inhibits the reaction [Serotonin results in increased expression of JUN protein]

NCBI chr 6:153,686,425...153,687,635
Ensembl chr 6:153,685,682...153,687,636

G

mitogen-activated protein kinase 1

multiple interactions

sarpogrelate inhibits the reaction [Serotonin results in increased phosphorylation of MAPK1 protein]

NCBI chr14:50,083,079...50,165,528
Ensembl chr14:50,082,896...50,165,513

G

mitogen-activated protein kinase 3

multiple interactions

sarpogrelate inhibits the reaction [Serotonin results in increased phosphorylation of MAPK3 protein]

NCBI chr 3:18,291,444...18,299,410
Ensembl chr 3:18,291,445...18,299,567

tamoxifen

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

estrogen receptor 1

affects binding

Tamoxifen metabolite binds to ESR1 protein

NCBI chr 1:14,217,032...14,604,906
Ensembl chr 1:14,217,036...14,493,363

Term paths to the root

Path 1
Term	Annotations
CHEBI ontology	5066
chemical entity	5066
atom	5057
nonmetal atom	5019
carbon atom	4939
organic molecular entity	4939
olefinic compound	4464
stilbenoid	229
(+)-cis-epsilon-viniferin	0
(+)-discoipyrrole A	0
(+)-trans-epsilon-viniferin	0
(-)-cis-epsilon-viniferin	0
(-)-discoipyrrole A	0
(-)-trans-epsilon-viniferin	0
(2-\{4-[3-(2-chloroethyl)-2,3-diphenyloxiran-2-yl]phenoxy\}ethyl)dimethylamine	0
(2E)-3-Ethyl-2-[(2Z)-2-[[3-ethyl-6-[(E)-2-phenylethenyl]-1,3-benzothiazol-3-ium-2-yl]methylidene]butylidene]-5,6-dimethyl-1,3-benzothiazole	0
(2E)-4-\{4-[2-(7-methoxy-1,3-benzodioxol-5-yl)ethyl]phenoxy\}-2-methyl-2-buten-1-ol	0
(2R,3R)-1-(1-adamantylmethyl)-2-[4-(hydroxymethyl)phenyl]-N-(2-methylpropyl)-3-(4-nitrophenyl)-5-oxo-3-pyrrolidinecarboxamide	0
(2R,3R)-cis-delta-viniferin	0
(2R,3R)-trans-delta-viniferin	0
(2R,3S)-cis-epsilon-viniferin	0
(2R,3S)-trans-epsilon-viniferin	0
(2S,3R)-1-(1-adamantylmethyl)-2-[4-(hydroxymethyl)-2-iodophenyl]-N-[2-(4-morpholinyl)ethyl]-3-(4-nitrophenyl)-5-oxo-3-pyrrolidinecarboxamide	0
(2S,3R)-cis-epsilon-viniferin	0
(2S,3R)-trans-epsilon-viniferin	0
(2S,3R,4S,5S,6R)-2-[3-hydroxy-5-[2-(4-hydroxyphenyl)ethenyl]phenoxy]-6-(hydroxymethyl)oxane-3,4,5-triol	0
(2S,3R,4S,5S,6R)-2-[3-hydroxy-5-[2-(4-methoxyphenyl)ethenyl]phenoxy]-6-(hydroxymethyl)oxane-3,4,5-triol	0
(2S,3S)-cis-delta-viniferin	0
(2S,3S)-trans-delta-viniferin	0
(3R,3'R,4'S,6'R,8'S,8'aS)-5-(4-hydroxybut-1-ynyl)-6'-[2-(2-hydroxyethoxy)phenyl]-8'-[oxo-[4-(2-pyrimidinyl)-1-piperazinyl]methyl]-3',4'-diphenylspiro[1H-indole-3,7'-4,6,8,8a-tetrahydro-3H-pyrrolo[2,1-c][1,4]oxazine]-1',2-dione	0
(3R,3'R,4'S,6'R,8'S,8'aS)-6'-(4-hydroxyphenyl)-1',2-dioxo-3',4'-diphenyl-8'-spiro[1H-indole-3,7'-4,6,8,8a-tetrahydro-3H-pyrrolo[2,1-c][1,4]oxazine]carboxamide	0
(3R,3'R,4'S,6'R,8'S,8'aS)-6'-[4-(2-hydroxyethoxy)phenyl]-1',2-dioxo-3',4'-diphenyl-8'-spiro[1H-indole-3,7'-4,6,8,8a-tetrahydro-3H-pyrrolo[2,1-c][1,4]oxazine]carboxamide	0
(3R,3'R,4'S,6'R,8'S,8'aS)-8'-[1-azocanyl(oxo)methyl]-5-[2-(1-cyclohexenyl)ethynyl]-6'-[4-(2-hydroxyethoxy)phenyl]-3',4'-diphenylspiro[1H-indole-3,7'-4,6,8,8a-tetrahydro-3H-pyrrolo[2,1-c][1,4]oxazine]-1',2-dione	0
(3R,4S,6R,7R,8S,8aS)-8-[(1,3-benzothiazol-2-ylamino)-oxomethyl]-5'-(4-hydroxybut-1-ynyl)-6-(4-hydroxyphenyl)-1,2'-dioxo-3,4-diphenyl-1'-spiro[4,6,8,8a-tetrahydro-3H-pyrrolo[2,1-c][1,4]oxazine-7,3'-indole]carboxylic acid 2-methoxyethyl ester	0
(3R,4S,6R,7R,8S,8aS)-8-carbamoyl-5'-[2-(1-cyclohexenyl)ethynyl]-6-[2-(2-hydroxyethoxy)phenyl]-1,2'-dioxo-3,4-diphenyl-1'-spiro[4,6,8,8a-tetrahydro-3H-pyrrolo[2,1-c][1,4]oxazine-7,3'-indole]carboxylic acid 2-methoxyethyl ester	0
(3R,5R)-5-[2-[2-[2-(3-methoxyphenyl)ethyl]phenoxy]ethyl]-1-methyl-3-pyrrolidinol	0
(3S,3'S,4'R,6'S,8'R,8'aR)-5-[2-(1-hydroxycycloheptyl)ethynyl]-6'-[4-(2-hydroxyethoxy)phenyl]-1',2-dioxo-3',4'-diphenyl-8'-spiro[1H-indole-3,7'-4,6,8,8a-tetrahydro-3H-pyrrolo[2,1-c][1,4]oxazine]carboxamide	0
(3S,3'S,4'R,6'S,8'R,8'aR)-5-[3-(carbamoylamino)prop-1-ynyl]-6'-[4-(2-hydroxyethoxy)phenyl]-1',2-dioxo-3',4'-diphenyl-N-prop-2-enyl-8'-spiro[1H-indole-3,7'-4,6,8,8a-tetrahydro-3H-pyrrolo[2,1-c][1,4]oxazine]carboxamide	0
(3S,3'S,4'R,6'S,8'R,8'aR)-6'-[2-(2-hydroxyethoxy)phenyl]-8'-[oxo-[4-(2-pyrimidinyl)-1-piperazinyl]methyl]-3',4'-diphenylspiro[1H-indole-3,7'-4,6,8,8a-tetrahydro-3H-pyrrolo[2,1-c][1,4]oxazine]-1',2-dione	0
(3S,3'S,4'R,6'S,8'R,8'aR)-6'-[4-[2-[[(3S,6R,7S,8aS)-6-(4-hydroxyphenyl)-3-(2-methylpropyl)-1,4-dioxo-2,3,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrazin-7-yl]-oxomethoxy]ethoxy]phenyl]-1',2-dioxo-3',4'-diphenyl-8'-spiro[1H-indole-3,7'-4,6,8,8a-tetrahydro-3H-pyrrolo[2,1-c][1,4]oxazine]carboxylic acid prop-2-enyl ester	0
(3S,3'S,4'R,6'S,8'R,8'aR)-8'-[(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)-oxomethyl]-6'-(4-hydroxyphenyl)-3',4'-diphenylspiro[1H-indole-3,7'-4,6,8,8a-tetrahydro-3H-pyrrolo[2,1-c][1,4]oxazine]-1',2-dione	0
(4S,5R)-N-(4-bromophenyl)-3-oxo-4,5-diphenyl-1-pyrazolidinecarboxamide	0
(E)-1-Methoxy-4-[2-(4-nitrophenyl)ethenyl]benzene	0
(E)-1-[4-Hydroxy-3-(3-methyl-1,3-butadienyl)phenyl]-2-(3,5-dihydroxyphenyl)ethylene	0
(E)-2,3,5,4'-tetrahydroxystilbene-2-O-beta-D-glucoside	0
(E)-2-Glucosyl-3,4',5-trihydroxystilbene	0
(E)-3,5-Dimethoxystilbene	0
(E)-4'-Methylresveratrol 3-glucoside	0
(E)-4-nitrostilbene	0
(E)-Arachidin II	0
(E)-Oxyresveratrol 3'-O-b-D-glucoside	0
(E)-Resveratrol 3-glucoside 4'-sulfate	0
(E)-Squamosamide	0
(E)-trans-miyabenol C	0
(R,S)-4-[1-Ethyl-2-(4-fluorophenyl)butyl]phenol	0
(Z)-4-Methoxy-3,3',5,5'-tetrahydroxystilbene	0
(Z)-4-glutaramidostilbene	0
(Z)-Resveratrol 3,4'-diglucoside	0
(Z)-Resveratrol 3-(2''-sulfoglucoside)	0
(Z)-Resveratrol 3-(3''-sulfoglucoside)	0
(Z)-Resveratrol 3-(6''-sulfoglucopyranoside)	0
(Z)-Resveratrol 3-glucoside 5-sulfate	0
(Z)-Resveratrol 4'-glucoside	0
(alphaS,betaS)-alpha-Ethyl-alpha-(4-methoxyphenyl)-beta-phenyl-2-pyridineethanol	0
1,1,2-Triphenylpropane	0
1,1-Diphenyl-2-(4-methoxyphenyl)propene	0
1,2,3-trimethoxy-5-[2-[4-(3-methylbut-2-enoxy)phenyl]ethyl]benzene	0
1,2-Bis(4-nitrophenyl)ethane	0
1-(1,2-diphenylethyl)piperidine	0
1-(2,3-dihydroxy-5-methylphenyl)-2-(2,4,6-trihydroxyphenyl)ethane-1,2-dione	0
1-(2,4-Dihydroxyphenyl)-2-(4-methoxyphenyl)ethanone	0
1-(2-fluorophenyl)-3-(4-morpholinyl)-2-phenyl-1-propanone	0
1-(3,4-dimethoxy-2-methylphenyl)-2-(3,4-dimethoxyphenyl)ethanone	0
1-(3,5-dimethyl-1-piperidinyl)-2,3-diphenyl-2-propen-1-one	0
1-(3,7-dihydroxy-2,2-dimethyl-3,4-dihydro-2H-1-benzopyran-6-yl)-2-(5-methoxy-2,2-dimethyl-1-benzopyran-6-yl)ethanone	0
1-(3-fluorophenyl)-3-(4-morpholinyl)-2-phenyl-1-propanone	0
1-(4-Chlorophenyl)-2-phenyl-2-propanol	0
1-(4-Methoxyphenyl)-2-phenylethane	0
1-(4-bromophenyl)-2-phenylethan-1-one	0
1-(4-bromophenyl)-3-(4-morpholinyl)-2-phenyl-1-propanone	0
1-(4-chlorophenyl)-3-(4-morpholinyl)-2-phenyl-1-propanol	0
1-(4-ethoxyphenyl)-3-(4-morpholinyl)-2-phenyl-1-propanol	0
1-(4-fluorophenyl)-2-phenyl-3-(1-piperidinyl)-1-propanone	0
1-(4-fluorophenyl)-2-phenyl-3-(1-pyrrolidinyl)-1-propanone	0
1-(4-fluorophenyl)-3-(4-methyl-1-piperazinyl)-2-phenyl-1-propanone	0
1-(4-fluorophenyl)-3-(4-morpholinyl)-2-phenyl-1-propanone	0
1-(4-hydroxyphenyl)-2-phenylethan-1-one	0
1-(4-methoxyphenyl)-3-(4-morpholinyl)-2-phenyl-1-propanone	0
1-[2-(2,4-dimethoxyphenyl)ethenyl]-3,5-dimethoxybenzene	0
1-chloro-4-\{4-[2-(dimethylamino)ethoxy]phenyl\}-3,4-diphenylbut-3-en-2-ol	0
2,2',4,4'-Tetrahydroxybenzil	0
2,3,3-Triphenylacrylonitrile	0
2,3-Bis(p-hydroxyphenyl)acrylonitrile	0
2,3-Bis(p-methoxyphenyl)acrylonitrile	0
2,3-Diphenyl-1-indanone	0
2,3-Diphenyl-3-(2-pyridinyl)acrylonitrile	0
2,4-Bis(3-methyl-2-butenyl)-5-(4-hydroxyphenethyl)resorcinol	0
2,5-Dimethoxystilbene	0
2,5-dihydroxy-4-(2-hydroxyphenyl)-5-(methylamino)-3-phenylpentanoic acid	0
2,6-Dimethylhexestrol	0
2-(2-Bromophenyl)-1-phenyl-2-propanol	0
2-(2-chloro-6-fluorophenyl)-1-(2,4-dihydroxyphenyl)ethanone	0
2-(3,4-dimethoxyphenyl)-1-(2,4,6-trihydroxyphenyl)ethanone	0
2-(3,7-Dimethylocta-2,6-dienyl)-3-methoxy-5-(2-phenylethyl)phenol	0
2-(3,7-Dimethylocta-2,6-dienyl)-5-(2-phenylethyl)benzene-1,3-diol	0
2-(4-Chlorophenyl)-3-phenyl-3-(2-pyridinyl)acrylonitrile	0
2-(4-bromophenyl)-1-(2,4-dihydroxyphenyl)ethanone	0
2-(4-chlorophenyl)-3-(4-fluorophenyl)-1-(4-morpholinyl)-3-heptanol	0
2-(p-Methoxyphenyl)-3-(m-chlorophenyl)acrylonitrile	0
2-Amino-1,2-bis(p-chlorophenyl)ethanol	0
2-Dehydro-O-desmethylangolensin	0
2-Hydroxy-4-methoxy-3-(3-methyl-2-butenyl)-6-(2-phenylethenyl)benzoic acid	0
2-Methoxy-1-(3-methyl-2-buten-1-yl)-4-[(Z)-2-phenylvinyl]benzene	0
2-[(2S)-2-[(2R)-2-morpholinyl]-2-phenylethyl]phenol	0
2-[(4,7-dimethyl-2-quinazolinyl)thio]-1,2-diphenylethanone	0
2-[(E)-2-[3,5-dihydroxy-4-(3-methylbut-2-en-1-yl)phenyl]ethenyl]benzene-1,3,5-triol	0
2-[3-Hydroxy-5-[2-(4-hydroxyphenyl)vinyl]phenoxy]-6-(hydroxymethyl)tetrahydropyran-3,4,5-triol	0
2-[3-[(3R,3'R,4'S,6'R,8'S,8'aS)-6'-[2-(2-hydroxyethoxy)phenyl]-1',2-dioxo-8'-[oxo-(prop-2-enylamino)methyl]-3',4'-diphenyl-5-spiro[1H-indole-3,7'-4,6,8,8a-tetrahydro-3H-pyrrolo[2,1-c][1,4]oxazine]yl]prop-2-ynyl]propanedioic acid dimethyl ester	0
2-[3-[(3R,3'R,4'S,6'R,8'S,8'aS)-6'-[2-(2-hydroxyethoxy)phenyl]-8'-[[[(2R)-2-hydroxy-2-phenylethyl]amino]-oxomethyl]-1',2-dioxo-3',4'-diphenyl-5-spiro[1H-indole-3,7'-4,6,8,8a-tetrahydro-3H-pyrrolo[2,1-c][1,4]oxazine]yl]prop-2-ynyl]propanedioic acid dimethyl ester	0
2-[3-[(3R,4S,6R,7R,8S,8aS)-6-[2-(2-hydroxyethoxy)phenyl]-1'-[2-methoxyethoxy(oxo)methyl]-1,2'-dioxo-8-[oxo-(prop-2-enylamino)methyl]-3,4-diphenyl-5'-spiro[4,6,8,8a-tetrahydro-3H-pyrrolo[2,1-c][1,4]oxazine-7,3'-indole]yl]prop-2-ynyl]propanedioic acid dimethyl ester	0
2-[3-[(3R,4S,6R,7R,8S,8aS)-6-[2-(2-hydroxyethoxy)phenyl]-1'-[2-methoxyethoxy(oxo)methyl]-1,2'-dioxo-8-[oxo-[4-(2-pyrimidinyl)-1-piperazinyl]methyl]-3,4-diphenyl-5'-spiro[4,6,8,8a-tetrahydro-3H-pyrrolo[2,1-c][1,4]oxazine-7,3'-indole]yl]prop-2-ynyl]propanedioic acid dimethyl ester	0
2-[3-[(3R,4S,6R,7R,8S,8aS)-6-[4-(2-hydroxyethoxy)phenyl]-1'-[2-methoxyethoxy(oxo)methyl]-1,2'-dioxo-8-[oxo-(prop-2-enylamino)methyl]-3,4-diphenyl-5'-spiro[4,6,8,8a-tetrahydro-3H-pyrrolo[2,1-c][1,4]oxazine-7,3'-indole]yl]prop-2-ynyl]propanedioic acid dimethyl ester	0
2-[3-[(3S,3'S,4'R,6'S,8'R,8'aR)-6'-[2-(2-hydroxyethoxy)phenyl]-1',2-dioxo-8'-[oxo-[4-(2-pyrimidinyl)-1-piperazinyl]methyl]-3',4'-diphenyl-5-spiro[1H-indole-3,7'-4,6,8,8a-tetrahydro-3H-pyrrolo[2,1-c][1,4]oxazine]yl]prop-2-ynyl]propanedioic acid dimethyl ester	0
2-[3-[(3S,3'S,4'R,6'S,8'R,8'aR)-8'-[1-azocanyl(oxo)methyl]-6'-(4-hydroxyphenyl)-1',2-dioxo-3',4'-diphenyl-5-spiro[1H-indole-3,7'-4,6,8,8a-tetrahydro-3H-pyrrolo[2,1-c][1,4]oxazine]yl]prop-2-ynyl]propanedioic acid dimethyl ester	0
2-[3-[(3S,3'S,4'R,6'S,8'R,8'aR)-8'-[1-azocanyl(oxo)methyl]-6'-[2-(2-hydroxyethoxy)phenyl]-1',2-dioxo-3',4'-diphenyl-5-spiro[1H-indole-3,7'-4,6,8,8a-tetrahydro-3H-pyrrolo[2,1-c][1,4]oxazine]yl]prop-2-ynyl]propanedioic acid dimethyl ester	0
2-[3-[(3S,4R,6S,7S,8R,8aR)-6-[2-(2-hydroxyethoxy)phenyl]-1'-[2-methoxyethoxy(oxo)methyl]-1,2'-dioxo-8-[oxo-[4-(2-pyrimidinyl)-1-piperazinyl]methyl]-3,4-diphenyl-5'-spiro[4,6,8,8a-tetrahydro-3H-pyrrolo[2,1-c][1,4]oxazine-7,3'-indole]yl]prop-2-ynyl]propanedioic acid dimethyl ester	0
2-[3-[(3S,4R,6S,7S,8R,8aR)-6-[4-(2-hydroxyethoxy)phenyl]-1'-[2-methoxyethoxy(oxo)methyl]-1,2'-dioxo-8-[oxo-[4-(2-pyrimidinyl)-1-piperazinyl]methyl]-3,4-diphenyl-5'-spiro[4,6,8,8a-tetrahydro-3H-pyrrolo[2,1-c][1,4]oxazine-7,3'-indole]yl]prop-2-ynyl]propanedioic acid dimethyl ester	0
2-[4,6-dihydroxy-2-methoxy-3-(3-methylbut-2-en-1-yl)phenyl]-1-(2,4,5-trihydroxyphenyl)ethan-1-one	0
2-[4-(1,2-diphenylbut-1-enyl)phenoxy]-N,N-dimethylethanamine	0
2-[4-(4-chloro-1,2-diphenylbut-1-enyl)phenoxy]-N,N-dimethylethanamine	0
2-\{4-[(1E)-1,2-diphenylbut-1-en-1-yl]phenoxy\}acetic acid	0
2-\{4-[(E)-2-(3,5-dihydroxyphenyl)ethenyl]-3-hydroxyphenoxy\}-6-(hydroxymethyl)oxane-3,4,5-triol	0
2-\{4-[(Z)-2-Chloro-1,2-diphenylvinyl]phenoxy\}-N-ethylethanamine	0
2-amino-N-(1,2-diphenylpropan-2-yl)acetamide	0
2-chloro-N-(1,2-diphenylethyl)acetamide	0
2-hydroxy-3,4-diphenylpentanedioic acid	0
2-naphthalenesulfonic acid propanoic acid [4-(dimethylamino)-3-methyl-1,2-diphenylbutan-2-yl] ester	0
3'-Hydroxy-3,4,5,4'-tetramethoxystilbene	0
3'-O-methylbatatasin III	0
3,3"-4-trimethoxybibenzyl	0
3,3'-Dihydroxyhexestrol	0
3,4,3',4'-tetrahydroxy-alpha,alpha'-diethylstilbene	0
3,4,5-trihydroxy-6-(2-hydroxy-1,2-diphenylethoxy)oxane-2-carboxylic acid	0
3,4,5-trihydroxy-6-(2-oxo-1,2-diphenylethoxy)oxane-2-carboxylic acid	0
3,4,5-trihydroxy-6-[2-(1-hydroxy-2-oxo-2-phenylethyl)phenoxy]oxane-2-carboxylic acid	0
3,4,5-trihydroxy-6-[3-(2-phenylcyclobutyl)phenoxy]oxane-2-carboxylic acid	0
3,4,5-trihydroxy-6-[5-hydroxy-3-methoxy-2-(3-methylbut-2-en-1-yl)-4-[2-oxo-2-(2,4,5-trihydroxyphenyl)ethyl]phenoxy]oxane-2-carboxylic acid	0
3,4,5-trihydroxy-6-\{2-hydroxy-6-methoxy-3-[1-oxo-1-(2,4,6-trihydroxyphenyl)propan-2-yl]phenoxy\}oxane-2-carboxylic acid	0
3,4,5-trihydroxy-6-\{3-[(E)-2-(2-hydroxy-4-\{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy\}phenyl)ethenyl]-5-\{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy\}phenoxy\}oxane-2-carboxylic acid	0
3,4,5-trihydroxy-6-\{3-hydroxy-2-[(1E)-4-hydroxy-3-methylbut-1-en-1-yl]-5-[(E)-2-(4-hydroxyphenyl)ethenyl]phenoxy\}oxane-2-carboxylic acid	0
3,4,5-trihydroxy-6-\{3-hydroxy-5-[(E)-2-(3-hydroxy-4-methoxyphenyl)ethenyl]phenoxy\}oxane-2-carboxylic acid	0
3,4,5-trihydroxy-6-\{3-hydroxy-5-[2-(2-hydroxyphenyl)ethyl]phenoxy\}oxane-2-carboxylic acid	0
3,4,5-trihydroxy-6-\{3-hydroxy-5-[2-(3-hydroxyphenyl)ethyl]phenoxy\}oxane-2-carboxylic acid	0
3,4,5-trihydroxy-6-\{4-[(E)-2-(3-hydroxy-5-\{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy\}phenyl)ethenyl]phenoxy\}oxane-2-carboxylic acid	0
3,4,5-trihydroxy-6-\{4-[(E)-2-\{2,3,5-trihydroxy-4-[(1E)-3-methylbut-1-en-1-yl]phenyl\}ethenyl]phenoxy\}oxane-2-carboxylic acid	0
3,4-bis(4-hydroxyphenyl)-1-(2-phenylethyl)pyrrole-2,5-dione	0
3,4-diphenylfuran-2(5H)-one	0
3,5,6-trihydroxy-1-methyl-4,5-diphenylpiperidin-2-one	0
3,5-dihydroxy-2-(2-(2-hydroxy-6-methylphenyl)-2-oxoethyl)-4-methylbenzaldehyde	0
3,5-dihydroxy-6-carbomethoxy-2-(3-methyl-2-butenyl)bibenzyl	0
3,6-dihydroxy-4,5-diphenyl-2,3,4,5-tetrahydropyridin-2-one	0
3-(1,3-dimethyl-2-oxo-5-benzimidazolyl)-2-(2-fluorophenyl)-2-propenenitrile	0
3-(2-methoxyphenyl)-2-phenyl-2-propenoic acid [2-(2,5-dimethylanilino)-2-oxoethyl] ester	0
3-(3-nitrophenyl)-2-phenylacrylic acid	0
3-(4-morpholinyl)-2-phenyl-1-[4-(trifluoromethyl)phenyl]-1-propanone	0
3-(diethylamino)-1-(4-fluorophenyl)-2-phenyl-1-propanone	0
3-(m-Aminophenyl)-2-(p-methoxyphenyl)acrylonitrile	0
3-Methoxy-5-(2-phenylethyl)-2-prenylphenol	0
3-[2-[2-chloro-4-[[3-(2,6-dichlorophenyl)-5-propan-2-yl-4-isoxazolyl]methoxy]phenyl]ethenyl]benzoic acid	0
3-[[(3R,4S)-2-(4-bromophenyl)-5-(3-chlorophenyl)-4-(2-methoxyphenyl)-3,4-dihydropyrazol-3-yl]-oxomethyl]-2-oxazolidinone	0
3-hydroxy-1-methyl-4,5-diphenylpiperidine-2,6-dione	0
3-hydroxy-4-(4-hydroxyphenyl)-1-methyl-5-phenylpiperidine-2,6-dione	0
3-hydroxy-5-methoxy-6-prenylstilbene-2-carboxylic acid	0
3-methoxy-5-(2-phenylethenyl)phenol	0
4'-Hydroxy-3,4,5-trimethoxystilbene	0
4'-Prenyloxyresveratrol	0
4,4'-(Diphenylethenylidene)bis[N,N-dimethylbenzenamine]	0
4,4'-(ethane-1,2-diyl)bis(2,3,6-trimethoxyphenol)	0
4,4'-Dihydroxybibenzyl	0
4,4'-Dinitrostilbene	0
4,4'-dihydroxy-3,5-dimethoxydihydrostilbene	0
4,5-diphenyl-1,5-dihydroimidazol-2-one	0
4-(1-Ethyl-2-phenylbutyl)phenol	0
4-(2-Phenylethyl)phenol	0
4-(3-Methyl-1-butenyl)-3,3',4',5-tetrahydroxystilbene	0
4-(3-Methyl-2-butenyl)-5-phenethylbenzene-1,3-diol	0
4-(dimethylamino)-1-(2-hydroxyphenyl)-3-methyl-2-phenylbutan-2-yl propanoate	0
4-(dimethylamino)-3-hydroxy-3-methyl-1,2-diphenylbutan-2-yl propanoate	0
4-(dimethylamino)-3-methyl-1,2-diphenylbutan-2-ol	0
4-Acetamido-4'-isothiocyanostilbene-2,2'-disulphonic acid	0
4-Chloro-alpha-[4-[2-(diethylamino)ethoxy]phenyl]-alpha-phenylbenzeneethanol	0
4-Hydroxy-3,5,4'-trimethoxystilbene	0
4-Hydroxy-N-desmethyltamoxifen	0
4-Hydroxytamoxifen sulfate	0
4-Hydroxytamoxifen-N-glucuronide	0
4-Methoxy-6-[2-[4-(3-methylbut-2-enoxy)phenyl]ethyl]-1,3-benzodioxole	0
4-O-Methylpinosylvic acid	0
4-Prenyldihydropinosylvin	0
4-Prenylresveratrol	0
4-[(1E)-1,2-diphenylbut-1-en-1-yl]phenol	0
4-[1-Ethyl-2-(4-methylphenyl)butyl]phenol	0
4-[1-[4-[2-(dimethylamino)ethoxy]phenyl]-1-phenylbut-1-en-2-yl]phenol	0
4-[1-[4-[2-(dimethylamino)ethoxy]phenyl]-2-phenylbut-1-enyl]phenol	0
4-[2-(2-methylphenyl)-2-oxoethyl]benzamide	0
4-[2-(3,5-dihydroxyphenyl)ethenyl]benzene-1,2-diol	0
4-[2-(5,5,8,8-tetramethyl-6,7-dihydronaphthalen-2-yl)prop-1-enyl]benzoic acid	0
4-[2-[3-bromo-4-[2-(4-hydroxyphenyl)ethenyl]phenyl]ethenyl]phenol	0
4-[4-(4-hydroxyphenyl)hex-3-en-3-yl]phenol	0
4-[[(4S,5R)-4,5-bis(4-chlorophenyl)-2-(4-methoxy-2-propan-2-yloxyphenyl)-4,5-dihydroimidazol-1-yl]-oxomethyl]-2-piperazinone	0
4-[[4,5-bis(4-chlorophenyl)-2-(4-methoxy-2-propan-2-yloxyphenyl)-4,5-dihydroimidazol-1-yl]-oxomethyl]-2-piperazinone	0
5,5'-(ethane-1,2-diyl)bis(3-bromobenzene-1,2-diol)	0
5,6-diphenyl-2,3-dihydropyrazine	0
5-(2-phenylethyl)-8-quinolinol	0
5-Benzyl-2,3-bis(4-methoxyphenyl)-1,4-dimethylpiperazine	0
5-[(4-Hydroxypheny)ethenyl]-2-(3-methyl-1-butenyl)-1,3-benzenediol	0
5-[(E)-1,2-Diphenylvinyl]-2-methoxyphenol	0
5-[(E)-2-(3,4-dihydroxyphenyl)ethenyl]-2-[(1E)-4-hydroxy-3-methylbut-1-en-1-yl]benzene-1,3-diol	0
5-[(E)-2-(3,5-dihydroxyphenyl)ethenyl]-2-methoxybenzene-1,3-diol	0
5-[(E)-2-(4-hydroxyphenyl)ethenyl]-2-[(1E)-3-methylbut1,3-dien-1-yl]benzene-1,3-diol	0
5-[2-(1-cyclohexenyl)ethynyl]-6'-[2-(2-hydroxyethoxy)phenyl]-N-(2-hydroxy-2-phenylethyl)-1',2-dioxo-3',4'-diphenyl-8'-spiro[1H-indole-3,7'-4,6,8,8a-tetrahydro-3H-pyrrolo[2,1-c][1,4]oxazine]carboxamide	0
5-[2-(2,6-difluorophenyl)ethyl]-8-quinolinol	0
5-[2-(4-aminophenyl)ethenyl]benzene-1,3-diol	0
5-[2-(4-ethoxy-2-hydroxyphenyl)-2-oxoethyl]-2-benzofurancarboxylic acid	0
5-[2-(4-methoxyphenyl)ethenyl]benzene-1,3-diol	0
5-[[4-[2-cyano-2-(4-fluorophenyl)ethenyl]-2-methoxyphenoxy]methyl]-2-furancarboxylic acid	0
5-amino-2,5-dihydroxy-3,4-diphenylpentanoic acid	0
6'-Hydroxy-O-desmethylangolensin	0
6'-Hydroxyangolensin	0
6-(4-\{3-[3,5-dihydroxy-4-(3-methylbut-2-en-1-yl)phenyl]oxiran-2-yl\}-3-hydroxyphenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid	0
6-(4-\{6-[2,4-dihydroxy-3-(3-methylbut-2-en-1-yl)benzoyl]-5-\{2,6-dihydroxy-4-[(E)-2-(2,4,5-trihydroxyphenyl)ethenyl]phenyl\}-3-methylcyclohex-3-en-1-yl\}-3-hydroxyphenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid	0
6-(4-\{6-[2,4-dihydroxy-3-(3-methylbut-2-en-1-yl)benzoyl]-5-\{4-[(E)-2-(2,4-dihydroxyphenyl)ethenyl]-2,6-dihydroxyphenyl\}-3-methylcyclohex-3-en-1-yl\}-3-hydroxyphenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid	0
6-Hydroxy-4-methoxy-3-(3-methyl-2-butenyl)-2-(2-phenylethenyl)benzoic acid	0
6-O-malonyl-trans-rhaponticin	0
6-[(E)-2-(2,4-dihydroxyphenyl)ethenyl]-3-(3-methylbut-2-en-1-yl)benzene-1,2,4-triol	0
6-[2-amino-5-(4-methoxyphenyl)-6-methyl-1H-pyrimidin-4-ylidene]-3-(2-methylprop-2-enoxy)-1-cyclohexa-2,4-dienone	0
6-[4-(2,3-dihydro-1,4-benzodioxin-6-yl)-5-methyl-1,2-dihydropyrazol-3-ylidene]-4-ethyl-3-hydroxy-1-cyclohexa-2,4-dienone	0
6-[4-(3,4-dimethoxyphenyl)-1,2-dihydropyrazol-3-ylidene]-3-[(4-nitrophenyl)methoxy]-1-cyclohexa-2,4-dienone	0
6-[4-(4-methoxyphenyl)-1,2-dihydropyrazol-3-ylidene]-3-(2-methylprop-2-enoxy)-1-cyclohexa-2,4-dienone	0
6-[6-(2,4-dihydroxyphenyl)-2-\{4-[(E)-2-(2,4-dihydroxyphenyl)ethenyl]-2,6-dihydroxyphenyl\}-4-methylcyclohex-3-ene-1-carbonyloxy]-3,4,5-trihydroxyoxane-2-carboxylic acid	0
6-[6-(2-\{2,6-dihydroxy-4-[(E)-2-(2,4,5-trihydroxyphenyl)ethenyl]phenyl\}-6-(2,4-dihydroxyphenyl)-4-methylcyclohex-3-ene-1-carbonyl)-3-hydroxy-2-(3-methylbut-2-en-1-yl)phenoxy]-3,4,5-trihydroxyoxane-2-carboxylic acid	0
6-\{2-[2-(2,4-dihydroxyphenyl)-2-oxoethyl]-5-hydroxy-3-methoxy-4-(3-methylbut-2-en-1-yl)phenoxy\}-3,4,5-trihydroxyoxane-2-carboxylic acid	0
6-\{2-[6-carboxy-5-(2,4-dihydroxyphenyl)-3-methylcyclohex-2-en-1-yl]-5-[(E)-2-(2,4-dihydroxyphenyl)ethenyl]-3-hydroxyphenoxy\}-3,4,5-trihydroxyoxane-2-carboxylic acid	0
6-\{3-[2-(2,5-dihydroxyphenyl)ethyl]-5-methoxyphenoxy\}-3,4,5-trihydroxyoxane-2-carboxylic acid	0
6-\{3-[2-(3,5-dihydroxyphenyl)ethyl]phenoxy\}-3,4,5-trihydroxyoxane-2-carboxylic acid	0
6-\{4-[(E)-2-\{3,5-dihydroxy-4-[(1E)-3-hydroxy-3-methylbut-1-en-1-yl]phenyl\}ethenyl]phenoxy\}-3,4,5-trihydroxyoxane-2-carboxylic acid	0
6-\{4-[(E)-2-\{4-[6-carboxy-5-(2,4-dihydroxyphenyl)-3-methylcyclohex-2-en-1-yl]-3,5-dihydroxyphenyl\}ethenyl]-3-hydroxyphenoxy\}-3,4,5-trihydroxyoxane-2-carboxylic acid	0
6-\{4-[2-(2,4-dihydroxyphenyl)-2-oxoethyl]-5-hydroxy-3-methoxy-2-(3-methylbut-2-en-1-yl)phenoxy\}-3,4,5-trihydroxyoxane-2-carboxylic acid	0
6-\{5-[(E)-2-(3,4-dihydroxyphenyl)ethenyl]-3-hydroxy-2-[(1E)-3-methylbuta-1,3-dien-1-yl]phenoxy\}-3,4,5-trihydroxyoxane-2-carboxylic acid	0
6-\{5-[(E)-2-(3,5-dihydroxyphenyl)ethenyl]-2-methoxyphenoxy\}-3,4,5-trihydroxyoxane-2-carboxylic acid	0
6-\{6-[6-(2,4-dihydroxyphenyl)-2-\{4-[(E)-2-(2,4-dihydroxyphenyl)ethenyl]-2,6-dihydroxyphenyl\}-4-(hydroxymethyl)cyclohex-3-ene-1-carbonyl]-3-hydroxy-2-(3-methylbut-2-en-1-yl)phenoxy\}-3,4,5-trihydroxyoxane-2-carboxylic acid	0
6-\{6-[6-(2,4-dihydroxyphenyl)-2-\{4-[(E)-2-(2,4-dihydroxyphenyl)ethenyl]-2,6-dihydroxyphenyl\}-4-methylcyclohex-3-ene-1-carbonyl]-3-hydroxy-2-(3-methylbut-2-en-1-yl)phenoxy\}-3,4,5-trihydroxyoxane-2-carboxylic acid	0
8'-[1-azocanyl(oxo)methyl]-6'-[2-(2-hydroxyethoxy)phenyl]-3',4'-diphenylspiro[1H-indole-3,7'-4,6,8,8a-tetrahydro-3H-pyrrolo[2,1-c][1,4]oxazine]-1',2-dione	0
Adlumidiceine	0
Alpha-Hydroxy-tamoxifen-O-glucuronide	0
Amorfrutin A	0
Amycolabenzoside A	0
Amycolabenzoside B	0
Aqabamycin A	0
Aqabamycin B	0
Aqabamycin C	0
Aqabamycin D	0
Artocarbene	0
Ascomindone A	0
Ascomindone B	0
BMS-453	0
BMS-493	0
Batatasin II	0
Batatasin III	0
Batatasin IV	0
Benvitimod	0
Benzene, 1,3-dimethoxy-5-(2-phenylethyl)-	0
CAY10616	0
Chlorophorin	0
Combretastatin A4	0
Demethylbatatasin IV	0
Desoxyrhaponticin	0
Diethylstilbestrol dimethyl ether	0
Diethylstilbestrol monomethyl ether	0
Diethylstilbestrol monosulfate	0
Dimethylstilbestrol	0
Discoipyrrole B	0
Discoipyrrole C	0
Discoipyrrole D	0
Droloxifene	0
Endoxifen sulfate	0
Ethamoxytriphetol	0
Fispemifene	0
G b1-G	0
GW 4064	0
Gaylussacin	0
Glepidotin C	0
Glicophenone	0
Hexestrol monomethyl ether	0
Homoclausenamide	0
Icariside E5	0
Idoxifene	0
Isoravenelone	0
Isorhapontigenin	0
Isorhapontin	0
Kocumarin	0
LSM-10158	0
LSM-10817	0
LSM-10952	0
LSM-14326	0
LSM-15164	0
LSM-15165	0
LSM-15166	0
LSM-2293	0
LSM-25341	0
LSM-25427	0
LSM-25443	0
LSM-25554	0
LSM-25594	0
LSM-30919	0
LSM-30949	0
LSM-31033	0
LSM-31136	0
LSM-3156	0
LSM-32014	0
LSM-36486	0
LSM-36488	0
LSM-36499	0
LSM-36502	0
LSM-36516	0
LSM-36521	0
LSM-36524	0
LSM-36527	0
LSM-36530	0
LSM-36535	0
LSM-36538	0
LSM-36543	0
LSM-36560	0
LSM-36585	0
LSM-37329	0
LSM-37359	0
LSM-37541	0
LSM-37607	0
LSM-37686	0
LSM-37688	0
LSM-37763	0
LSM-37818	0
LSM-38122	0
LSM-38169	0
LSM-38290	0
LSM-38370	0
LSM-38388	0
LSM-38591	0
LSM-38601	0
LSM-38772	0
LSM-38795	0
LSM-38819	0
LSM-38929	0
LSM-38931	0
LSM-38988	0
LSM-39133	0
LSM-39555	0
LSM-39628	0
LSM-39641	0
LSM-39795	0
LSM-39933	0
LSM-39981	0
LSM-40016	0
LSM-40078	0
LSM-40283	0
LSM-40335	0
LSM-40342	0
LSM-40463	0
LSM-40740	0
LSM-40782	0
LSM-40858	0
LSM-40879	0
LSM-40882	0
LSM-40920	0
LSM-40958	0
LSM-41014	0
LSM-41021	0
LSM-41042	0
LSM-41094	0
LSM-41206	0
LSM-41267	0
LSM-41324	0
LSM-41329	0
LSM-41367	0
LSM-41450	0
LSM-41475	0
LSM-41813	0
LSM-41881	0
LSM-41924	0
LSM-41934	0
LSM-41942	0
LSM-42016	0
LSM-42024	0
LSM-42106	0
LSM-42235	0
LSM-42264	0
LSM-42314	0
LSM-42427	0
LSM-42465	0
LSM-42468	0
LSM-42473	0
LSM-42537	0
LSM-42666	0
LSM-6991	0
LSM-7019	0
LSM-7029	0
LSM-7035	0
LSM-7046	0
LSM-7170	0
LSM-7212	0
LSM-7363	0
LSM-7460	0
LSM-7495	0
LSM-7560	0
LSM-7622	0
LSM-7741	0
LSM-7770	0
LSM-7838	0
LSM-7866	0
LSM-7904	0
LSM-7915	0
LSM-8088	0
LSM-8412	0
Lansamide 3	0
Lefetamine hydrochloride	0
Licoagrodione	0
Licoriphenone	0
Longistylin A	0
Longistylin C	0
Lucidumin B	0
Lunularic acid	0
Lunularin	0
Machaeriol C	0
Metaflumizone	0
Methoxy hydroxy stilbene carboxylic acid	0
Methyl 3-anilino-2-(1,7-dimethyl-1H-indol-3-yl)-2,3-diphenylpropanoate	0
N,2,3-triphenyl-2-propenamide	0
N,N-Didesmethyltamoxifen	0
N-(2,6-diethylphenyl)-2,3-diphenyl-2-propenamide	0
N-Desmethyltamoxifen	0
N-Methylnarceimicine	0
N-desmethyltoremifene	0
N-ethyl-5-(4-hydroxy-6-oxo-3-propan-2-yl-1-cyclohexa-2,4-dienylidene)-4-[4-(4-morpholinylmethyl)phenyl]-2H-isoxazole-3-carboxamide	0
NCGC00385051-01	0
Narceine	0
Narceinone	0
Nicofetamide	0
Norendoxifen	0
Norpropoxyphene	0
O-Desmethylangolensin	0
Oxyresveratrol	0
Phenol, 5-[(1z)-2-(3,5-dimethoxyphenyl)ethenyl]-2-methoxy-	0
Piceatannol 3,4'-diglucoside	0
Piceatannol 4'-galloylglucoside	0
Piceatannol 4'-glucoside	0
Pinostilbenoside	0
Pinosylvin methyl ether	0
Pulveraven A	0
Pulveraven B	0
Radulannin A	0
Radulannin H	0
Radulannin L	0
Ravenelone	0
Resveratrodehyde A	0
Resveratrodehyde B	0
Resveratrodehyde C	0
Resveratrol 4'-(2-galloylglucoside)	0
Resveratrol 4'-(6-galloylglucoside)	0
Rhapontigenin	0
S-3-hydroxy-4,5-diphenylfuran-2(5H)-one	0
SC-57666	0
Salvianolic acid A	0
Sarpogrelate hydrochloride	0
Stilbostemin F	0
Sucrose 1',4'-(4,4'-dihydroxy-3,3'-dimethoxy-b-truxinate)	0
Sumarotene	0
Taranabant	0
Tetraphenylcyclopentadienone	0
Toremifene citrate	0
Trimethyl(\{2-[4-(2-\{4-[2-(trimethylazaniumyl)ethoxy]phenyl\}pentyl)phenoxy]ethyl\})azanium diiodide	0
Triphenylethylene	0
Verimol D	0
[(4-\{3-[2-(2,4-dihydroxyphenyl)-2-oxoethyl]-4,6-dihydroxy-2-methoxyphenyl\}-2-methylbut-2-en-1-yl)oxy]sulfonic acid	0
[4-(2-phenylcyclobutyl)phenyl]oxidanesulfonic acid	0
[4-(3-\{3,5-dihydroxy-4-[(1E)-3-methylbut-1-en-1-yl]phenyl\}oxiran-2-yl)phenyl]oxidanesulfonic acid	0
[4-methoxy-2-[2-[5-methoxy-2-(oxidoazaniumyl)phenyl]ethyl]phenyl]-oxidoazanium	0
\{4-[(1e)-4-chloro-1,2-diphenyl-1-buten-1-yl]phenoxy\}acetaldehyde	0
\{4-[(E)-2-\{3,5-dihydroxy-4-[(1E)-3-methylbut-1-en-1-yl]phenyl\}ethenyl]phenyl\}oxidanesulfonic acid	0
\{4-[3-(3,5-dihydroxyphenyl)oxiran-2-yl]phenyl\}oxidanesulfonic acid	0
acetic acid [4-[2-(3,5-diacetyloxyphenyl)ethenyl]phenyl] ester	0
aiphanol	0
alpha,alpha'-Diethyl-3,4,4'-stilbenetriol	0
alpha,alpha'-Diethyl-4,4'-bis(2-propynyloxy)stilbene	0
alpha-Ethyl-alpha,beta-diphenyl-2-pyridineethanol	0
alpha-Hydroxy-N-desmethyltamoxifen	0
alpha-Hydroxytamoxifen	0
aminoxytriphene	0
ampelopsin B	0
bibenzonium	0
cinnamaverine	0
cis-Mulberroside A	0
cis-Resveratrol 3-sulfate	0
cis-Resveratrol 4'-O-glucuronide	0
cis-Resveratrol 4'-sulfate	0
cis-astringin	0
cis-piceid	0
diethylaminoethoxyhexestrol	0
florbetaben ((18)F)	0
hexestrol	0
hydroxystilbamidine	0
lefetamine	0
lignin cw compound-172	0
lignin cw compound-2019	0
lignin cw compound-2053	0
lignin cw compound-2054	0
lignin cw compound-3007	0
lignin cw compound-3030	0
m-(beta-Acetyl-alpha-ethyl-p-hydroxyphenethyl)benzoic acid	0
methestrol	0
methestrol dipropionate	0
nepalensinol D	0
nepalensinol E	0
nepalensinol F	0
p-Methoxystilbene	0
pallidol	0
palovarotene	0
pheniodol sodium	0
phoyunbene A	0
phoyunbene B	0
phoyunbene C	0
phoyunbene D	0
poacic acid	0
pyrrobutamine	0
quadrangularin A	0
rhaponticin +	0
sarpogrelate	4
schweinfurthin E	0
schweinfurthin F	0
schweinfurthin G	0
schweinfurthin H	0
stilbenol +	226
tamoxifen +	1
trans-2-(4-Methoxyphenyl)-3-(4-nitrophenyl)oxirane	0
trans-Resveratrol 3,4'-disulfate	0
trans-Resveratrol 3,5-disulfate	0
trans-Resveratrol 3-O-glucuronide	0
trans-Resveratrol 4'-O-glucuronide	0
trans-astringin	0
trans-diptoindonesin B	0
trans-piceid	0
triparanol	0
vedelianin +	0
zuclomifene	0
Path 2
Term	Annotations
CHEBI ontology	5066
subatomic particle	5057
composite particle	5057
hadron	5057
baryon	5057
nucleon	5057
atomic nucleus	5057
atom	5057
main group element atom	5026
p-block element atom	5023
carbon group element atom	4940
carbon atom	4939
organic molecular entity	4939
organic molecule	4887
organic cyclic compound	4825
organic aromatic compound	813
stilbenoid	229
(+)-cis-epsilon-viniferin	0
(+)-discoipyrrole A	0
(+)-trans-epsilon-viniferin	0
(-)-cis-epsilon-viniferin	0
(-)-discoipyrrole A	0
(-)-trans-epsilon-viniferin	0
(2-\{4-[3-(2-chloroethyl)-2,3-diphenyloxiran-2-yl]phenoxy\}ethyl)dimethylamine	0
(2E)-3-Ethyl-2-[(2Z)-2-[[3-ethyl-6-[(E)-2-phenylethenyl]-1,3-benzothiazol-3-ium-2-yl]methylidene]butylidene]-5,6-dimethyl-1,3-benzothiazole	0
(2E)-4-\{4-[2-(7-methoxy-1,3-benzodioxol-5-yl)ethyl]phenoxy\}-2-methyl-2-buten-1-ol	0
(2R,3R)-1-(1-adamantylmethyl)-2-[4-(hydroxymethyl)phenyl]-N-(2-methylpropyl)-3-(4-nitrophenyl)-5-oxo-3-pyrrolidinecarboxamide	0
(2R,3R)-cis-delta-viniferin	0
(2R,3R)-trans-delta-viniferin	0
(2R,3S)-cis-epsilon-viniferin	0
(2R,3S)-trans-epsilon-viniferin	0
(2S,3R)-1-(1-adamantylmethyl)-2-[4-(hydroxymethyl)-2-iodophenyl]-N-[2-(4-morpholinyl)ethyl]-3-(4-nitrophenyl)-5-oxo-3-pyrrolidinecarboxamide	0
(2S,3R)-cis-epsilon-viniferin	0
(2S,3R)-trans-epsilon-viniferin	0
(2S,3R,4S,5S,6R)-2-[3-hydroxy-5-[2-(4-hydroxyphenyl)ethenyl]phenoxy]-6-(hydroxymethyl)oxane-3,4,5-triol	0
(2S,3R,4S,5S,6R)-2-[3-hydroxy-5-[2-(4-methoxyphenyl)ethenyl]phenoxy]-6-(hydroxymethyl)oxane-3,4,5-triol	0
(2S,3S)-cis-delta-viniferin	0
(2S,3S)-trans-delta-viniferin	0
(3R,3'R,4'S,6'R,8'S,8'aS)-5-(4-hydroxybut-1-ynyl)-6'-[2-(2-hydroxyethoxy)phenyl]-8'-[oxo-[4-(2-pyrimidinyl)-1-piperazinyl]methyl]-3',4'-diphenylspiro[1H-indole-3,7'-4,6,8,8a-tetrahydro-3H-pyrrolo[2,1-c][1,4]oxazine]-1',2-dione	0
(3R,3'R,4'S,6'R,8'S,8'aS)-6'-(4-hydroxyphenyl)-1',2-dioxo-3',4'-diphenyl-8'-spiro[1H-indole-3,7'-4,6,8,8a-tetrahydro-3H-pyrrolo[2,1-c][1,4]oxazine]carboxamide	0
(3R,3'R,4'S,6'R,8'S,8'aS)-6'-[4-(2-hydroxyethoxy)phenyl]-1',2-dioxo-3',4'-diphenyl-8'-spiro[1H-indole-3,7'-4,6,8,8a-tetrahydro-3H-pyrrolo[2,1-c][1,4]oxazine]carboxamide	0
(3R,3'R,4'S,6'R,8'S,8'aS)-8'-[1-azocanyl(oxo)methyl]-5-[2-(1-cyclohexenyl)ethynyl]-6'-[4-(2-hydroxyethoxy)phenyl]-3',4'-diphenylspiro[1H-indole-3,7'-4,6,8,8a-tetrahydro-3H-pyrrolo[2,1-c][1,4]oxazine]-1',2-dione	0
(3R,4S,6R,7R,8S,8aS)-8-[(1,3-benzothiazol-2-ylamino)-oxomethyl]-5'-(4-hydroxybut-1-ynyl)-6-(4-hydroxyphenyl)-1,2'-dioxo-3,4-diphenyl-1'-spiro[4,6,8,8a-tetrahydro-3H-pyrrolo[2,1-c][1,4]oxazine-7,3'-indole]carboxylic acid 2-methoxyethyl ester	0
(3R,4S,6R,7R,8S,8aS)-8-carbamoyl-5'-[2-(1-cyclohexenyl)ethynyl]-6-[2-(2-hydroxyethoxy)phenyl]-1,2'-dioxo-3,4-diphenyl-1'-spiro[4,6,8,8a-tetrahydro-3H-pyrrolo[2,1-c][1,4]oxazine-7,3'-indole]carboxylic acid 2-methoxyethyl ester	0
(3R,5R)-5-[2-[2-[2-(3-methoxyphenyl)ethyl]phenoxy]ethyl]-1-methyl-3-pyrrolidinol	0
(3S,3'S,4'R,6'S,8'R,8'aR)-5-[2-(1-hydroxycycloheptyl)ethynyl]-6'-[4-(2-hydroxyethoxy)phenyl]-1',2-dioxo-3',4'-diphenyl-8'-spiro[1H-indole-3,7'-4,6,8,8a-tetrahydro-3H-pyrrolo[2,1-c][1,4]oxazine]carboxamide	0
(3S,3'S,4'R,6'S,8'R,8'aR)-5-[3-(carbamoylamino)prop-1-ynyl]-6'-[4-(2-hydroxyethoxy)phenyl]-1',2-dioxo-3',4'-diphenyl-N-prop-2-enyl-8'-spiro[1H-indole-3,7'-4,6,8,8a-tetrahydro-3H-pyrrolo[2,1-c][1,4]oxazine]carboxamide	0
(3S,3'S,4'R,6'S,8'R,8'aR)-6'-[2-(2-hydroxyethoxy)phenyl]-8'-[oxo-[4-(2-pyrimidinyl)-1-piperazinyl]methyl]-3',4'-diphenylspiro[1H-indole-3,7'-4,6,8,8a-tetrahydro-3H-pyrrolo[2,1-c][1,4]oxazine]-1',2-dione	0
(3S,3'S,4'R,6'S,8'R,8'aR)-6'-[4-[2-[[(3S,6R,7S,8aS)-6-(4-hydroxyphenyl)-3-(2-methylpropyl)-1,4-dioxo-2,3,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrazin-7-yl]-oxomethoxy]ethoxy]phenyl]-1',2-dioxo-3',4'-diphenyl-8'-spiro[1H-indole-3,7'-4,6,8,8a-tetrahydro-3H-pyrrolo[2,1-c][1,4]oxazine]carboxylic acid prop-2-enyl ester	0
(3S,3'S,4'R,6'S,8'R,8'aR)-8'-[(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)-oxomethyl]-6'-(4-hydroxyphenyl)-3',4'-diphenylspiro[1H-indole-3,7'-4,6,8,8a-tetrahydro-3H-pyrrolo[2,1-c][1,4]oxazine]-1',2-dione	0
(4S,5R)-N-(4-bromophenyl)-3-oxo-4,5-diphenyl-1-pyrazolidinecarboxamide	0
(E)-1-Methoxy-4-[2-(4-nitrophenyl)ethenyl]benzene	0
(E)-1-[4-Hydroxy-3-(3-methyl-1,3-butadienyl)phenyl]-2-(3,5-dihydroxyphenyl)ethylene	0
(E)-2,3,5,4'-tetrahydroxystilbene-2-O-beta-D-glucoside	0
(E)-2-Glucosyl-3,4',5-trihydroxystilbene	0
(E)-3,5-Dimethoxystilbene	0
(E)-4'-Methylresveratrol 3-glucoside	0
(E)-4-nitrostilbene	0
(E)-Arachidin II	0
(E)-Oxyresveratrol 3'-O-b-D-glucoside	0
(E)-Resveratrol 3-glucoside 4'-sulfate	0
(E)-Squamosamide	0
(E)-trans-miyabenol C	0
(R,S)-4-[1-Ethyl-2-(4-fluorophenyl)butyl]phenol	0
(Z)-4-Methoxy-3,3',5,5'-tetrahydroxystilbene	0
(Z)-4-glutaramidostilbene	0
(Z)-Resveratrol 3,4'-diglucoside	0
(Z)-Resveratrol 3-(2''-sulfoglucoside)	0
(Z)-Resveratrol 3-(3''-sulfoglucoside)	0
(Z)-Resveratrol 3-(6''-sulfoglucopyranoside)	0
(Z)-Resveratrol 3-glucoside 5-sulfate	0
(Z)-Resveratrol 4'-glucoside	0
(alphaS,betaS)-alpha-Ethyl-alpha-(4-methoxyphenyl)-beta-phenyl-2-pyridineethanol	0
1,1,2-Triphenylpropane	0
1,1-Diphenyl-2-(4-methoxyphenyl)propene	0
1,2,3-trimethoxy-5-[2-[4-(3-methylbut-2-enoxy)phenyl]ethyl]benzene	0
1,2-Bis(4-nitrophenyl)ethane	0
1-(1,2-diphenylethyl)piperidine	0
1-(2,3-dihydroxy-5-methylphenyl)-2-(2,4,6-trihydroxyphenyl)ethane-1,2-dione	0
1-(2,4-Dihydroxyphenyl)-2-(4-methoxyphenyl)ethanone	0
1-(2-fluorophenyl)-3-(4-morpholinyl)-2-phenyl-1-propanone	0
1-(3,4-dimethoxy-2-methylphenyl)-2-(3,4-dimethoxyphenyl)ethanone	0
1-(3,5-dimethyl-1-piperidinyl)-2,3-diphenyl-2-propen-1-one	0
1-(3,7-dihydroxy-2,2-dimethyl-3,4-dihydro-2H-1-benzopyran-6-yl)-2-(5-methoxy-2,2-dimethyl-1-benzopyran-6-yl)ethanone	0
1-(3-fluorophenyl)-3-(4-morpholinyl)-2-phenyl-1-propanone	0
1-(4-Chlorophenyl)-2-phenyl-2-propanol	0
1-(4-Methoxyphenyl)-2-phenylethane	0
1-(4-bromophenyl)-2-phenylethan-1-one	0
1-(4-bromophenyl)-3-(4-morpholinyl)-2-phenyl-1-propanone	0
1-(4-chlorophenyl)-3-(4-morpholinyl)-2-phenyl-1-propanol	0
1-(4-ethoxyphenyl)-3-(4-morpholinyl)-2-phenyl-1-propanol	0
1-(4-fluorophenyl)-2-phenyl-3-(1-piperidinyl)-1-propanone	0
1-(4-fluorophenyl)-2-phenyl-3-(1-pyrrolidinyl)-1-propanone	0
1-(4-fluorophenyl)-3-(4-methyl-1-piperazinyl)-2-phenyl-1-propanone	0
1-(4-fluorophenyl)-3-(4-morpholinyl)-2-phenyl-1-propanone	0
1-(4-hydroxyphenyl)-2-phenylethan-1-one	0
1-(4-methoxyphenyl)-3-(4-morpholinyl)-2-phenyl-1-propanone	0
1-[2-(2,4-dimethoxyphenyl)ethenyl]-3,5-dimethoxybenzene	0
1-chloro-4-\{4-[2-(dimethylamino)ethoxy]phenyl\}-3,4-diphenylbut-3-en-2-ol	0
2,2',4,4'-Tetrahydroxybenzil	0
2,3,3-Triphenylacrylonitrile	0
2,3-Bis(p-hydroxyphenyl)acrylonitrile	0
2,3-Bis(p-methoxyphenyl)acrylonitrile	0
2,3-Diphenyl-1-indanone	0
2,3-Diphenyl-3-(2-pyridinyl)acrylonitrile	0
2,4-Bis(3-methyl-2-butenyl)-5-(4-hydroxyphenethyl)resorcinol	0
2,5-Dimethoxystilbene	0
2,5-dihydroxy-4-(2-hydroxyphenyl)-5-(methylamino)-3-phenylpentanoic acid	0
2,6-Dimethylhexestrol	0
2-(2-Bromophenyl)-1-phenyl-2-propanol	0
2-(2-chloro-6-fluorophenyl)-1-(2,4-dihydroxyphenyl)ethanone	0
2-(3,4-dimethoxyphenyl)-1-(2,4,6-trihydroxyphenyl)ethanone	0
2-(3,7-Dimethylocta-2,6-dienyl)-3-methoxy-5-(2-phenylethyl)phenol	0
2-(3,7-Dimethylocta-2,6-dienyl)-5-(2-phenylethyl)benzene-1,3-diol	0
2-(4-Chlorophenyl)-3-phenyl-3-(2-pyridinyl)acrylonitrile	0
2-(4-bromophenyl)-1-(2,4-dihydroxyphenyl)ethanone	0
2-(4-chlorophenyl)-3-(4-fluorophenyl)-1-(4-morpholinyl)-3-heptanol	0
2-(p-Methoxyphenyl)-3-(m-chlorophenyl)acrylonitrile	0
2-Amino-1,2-bis(p-chlorophenyl)ethanol	0
2-Dehydro-O-desmethylangolensin	0
2-Hydroxy-4-methoxy-3-(3-methyl-2-butenyl)-6-(2-phenylethenyl)benzoic acid	0
2-Methoxy-1-(3-methyl-2-buten-1-yl)-4-[(Z)-2-phenylvinyl]benzene	0
2-[(2S)-2-[(2R)-2-morpholinyl]-2-phenylethyl]phenol	0
2-[(4,7-dimethyl-2-quinazolinyl)thio]-1,2-diphenylethanone	0
2-[(E)-2-[3,5-dihydroxy-4-(3-methylbut-2-en-1-yl)phenyl]ethenyl]benzene-1,3,5-triol	0
2-[3-Hydroxy-5-[2-(4-hydroxyphenyl)vinyl]phenoxy]-6-(hydroxymethyl)tetrahydropyran-3,4,5-triol	0
2-[3-[(3R,3'R,4'S,6'R,8'S,8'aS)-6'-[2-(2-hydroxyethoxy)phenyl]-1',2-dioxo-8'-[oxo-(prop-2-enylamino)methyl]-3',4'-diphenyl-5-spiro[1H-indole-3,7'-4,6,8,8a-tetrahydro-3H-pyrrolo[2,1-c][1,4]oxazine]yl]prop-2-ynyl]propanedioic acid dimethyl ester	0
2-[3-[(3R,3'R,4'S,6'R,8'S,8'aS)-6'-[2-(2-hydroxyethoxy)phenyl]-8'-[[[(2R)-2-hydroxy-2-phenylethyl]amino]-oxomethyl]-1',2-dioxo-3',4'-diphenyl-5-spiro[1H-indole-3,7'-4,6,8,8a-tetrahydro-3H-pyrrolo[2,1-c][1,4]oxazine]yl]prop-2-ynyl]propanedioic acid dimethyl ester	0
2-[3-[(3R,4S,6R,7R,8S,8aS)-6-[2-(2-hydroxyethoxy)phenyl]-1'-[2-methoxyethoxy(oxo)methyl]-1,2'-dioxo-8-[oxo-(prop-2-enylamino)methyl]-3,4-diphenyl-5'-spiro[4,6,8,8a-tetrahydro-3H-pyrrolo[2,1-c][1,4]oxazine-7,3'-indole]yl]prop-2-ynyl]propanedioic acid dimethyl ester	0
2-[3-[(3R,4S,6R,7R,8S,8aS)-6-[2-(2-hydroxyethoxy)phenyl]-1'-[2-methoxyethoxy(oxo)methyl]-1,2'-dioxo-8-[oxo-[4-(2-pyrimidinyl)-1-piperazinyl]methyl]-3,4-diphenyl-5'-spiro[4,6,8,8a-tetrahydro-3H-pyrrolo[2,1-c][1,4]oxazine-7,3'-indole]yl]prop-2-ynyl]propanedioic acid dimethyl ester	0
2-[3-[(3R,4S,6R,7R,8S,8aS)-6-[4-(2-hydroxyethoxy)phenyl]-1'-[2-methoxyethoxy(oxo)methyl]-1,2'-dioxo-8-[oxo-(prop-2-enylamino)methyl]-3,4-diphenyl-5'-spiro[4,6,8,8a-tetrahydro-3H-pyrrolo[2,1-c][1,4]oxazine-7,3'-indole]yl]prop-2-ynyl]propanedioic acid dimethyl ester	0
2-[3-[(3S,3'S,4'R,6'S,8'R,8'aR)-6'-[2-(2-hydroxyethoxy)phenyl]-1',2-dioxo-8'-[oxo-[4-(2-pyrimidinyl)-1-piperazinyl]methyl]-3',4'-diphenyl-5-spiro[1H-indole-3,7'-4,6,8,8a-tetrahydro-3H-pyrrolo[2,1-c][1,4]oxazine]yl]prop-2-ynyl]propanedioic acid dimethyl ester	0
2-[3-[(3S,3'S,4'R,6'S,8'R,8'aR)-8'-[1-azocanyl(oxo)methyl]-6'-(4-hydroxyphenyl)-1',2-dioxo-3',4'-diphenyl-5-spiro[1H-indole-3,7'-4,6,8,8a-tetrahydro-3H-pyrrolo[2,1-c][1,4]oxazine]yl]prop-2-ynyl]propanedioic acid dimethyl ester	0
2-[3-[(3S,3'S,4'R,6'S,8'R,8'aR)-8'-[1-azocanyl(oxo)methyl]-6'-[2-(2-hydroxyethoxy)phenyl]-1',2-dioxo-3',4'-diphenyl-5-spiro[1H-indole-3,7'-4,6,8,8a-tetrahydro-3H-pyrrolo[2,1-c][1,4]oxazine]yl]prop-2-ynyl]propanedioic acid dimethyl ester	0
2-[3-[(3S,4R,6S,7S,8R,8aR)-6-[2-(2-hydroxyethoxy)phenyl]-1'-[2-methoxyethoxy(oxo)methyl]-1,2'-dioxo-8-[oxo-[4-(2-pyrimidinyl)-1-piperazinyl]methyl]-3,4-diphenyl-5'-spiro[4,6,8,8a-tetrahydro-3H-pyrrolo[2,1-c][1,4]oxazine-7,3'-indole]yl]prop-2-ynyl]propanedioic acid dimethyl ester	0
2-[3-[(3S,4R,6S,7S,8R,8aR)-6-[4-(2-hydroxyethoxy)phenyl]-1'-[2-methoxyethoxy(oxo)methyl]-1,2'-dioxo-8-[oxo-[4-(2-pyrimidinyl)-1-piperazinyl]methyl]-3,4-diphenyl-5'-spiro[4,6,8,8a-tetrahydro-3H-pyrrolo[2,1-c][1,4]oxazine-7,3'-indole]yl]prop-2-ynyl]propanedioic acid dimethyl ester	0
2-[4,6-dihydroxy-2-methoxy-3-(3-methylbut-2-en-1-yl)phenyl]-1-(2,4,5-trihydroxyphenyl)ethan-1-one	0
2-[4-(1,2-diphenylbut-1-enyl)phenoxy]-N,N-dimethylethanamine	0
2-[4-(4-chloro-1,2-diphenylbut-1-enyl)phenoxy]-N,N-dimethylethanamine	0
2-\{4-[(1E)-1,2-diphenylbut-1-en-1-yl]phenoxy\}acetic acid	0
2-\{4-[(E)-2-(3,5-dihydroxyphenyl)ethenyl]-3-hydroxyphenoxy\}-6-(hydroxymethyl)oxane-3,4,5-triol	0
2-\{4-[(Z)-2-Chloro-1,2-diphenylvinyl]phenoxy\}-N-ethylethanamine	0
2-amino-N-(1,2-diphenylpropan-2-yl)acetamide	0
2-chloro-N-(1,2-diphenylethyl)acetamide	0
2-hydroxy-3,4-diphenylpentanedioic acid	0
2-naphthalenesulfonic acid propanoic acid [4-(dimethylamino)-3-methyl-1,2-diphenylbutan-2-yl] ester	0
3'-Hydroxy-3,4,5,4'-tetramethoxystilbene	0
3'-O-methylbatatasin III	0
3,3"-4-trimethoxybibenzyl	0
3,3'-Dihydroxyhexestrol	0
3,4,3',4'-tetrahydroxy-alpha,alpha'-diethylstilbene	0
3,4,5-trihydroxy-6-(2-hydroxy-1,2-diphenylethoxy)oxane-2-carboxylic acid	0
3,4,5-trihydroxy-6-(2-oxo-1,2-diphenylethoxy)oxane-2-carboxylic acid	0
3,4,5-trihydroxy-6-[2-(1-hydroxy-2-oxo-2-phenylethyl)phenoxy]oxane-2-carboxylic acid	0
3,4,5-trihydroxy-6-[3-(2-phenylcyclobutyl)phenoxy]oxane-2-carboxylic acid	0
3,4,5-trihydroxy-6-[5-hydroxy-3-methoxy-2-(3-methylbut-2-en-1-yl)-4-[2-oxo-2-(2,4,5-trihydroxyphenyl)ethyl]phenoxy]oxane-2-carboxylic acid	0
3,4,5-trihydroxy-6-\{2-hydroxy-6-methoxy-3-[1-oxo-1-(2,4,6-trihydroxyphenyl)propan-2-yl]phenoxy\}oxane-2-carboxylic acid	0
3,4,5-trihydroxy-6-\{3-[(E)-2-(2-hydroxy-4-\{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy\}phenyl)ethenyl]-5-\{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy\}phenoxy\}oxane-2-carboxylic acid	0
3,4,5-trihydroxy-6-\{3-hydroxy-2-[(1E)-4-hydroxy-3-methylbut-1-en-1-yl]-5-[(E)-2-(4-hydroxyphenyl)ethenyl]phenoxy\}oxane-2-carboxylic acid	0
3,4,5-trihydroxy-6-\{3-hydroxy-5-[(E)-2-(3-hydroxy-4-methoxyphenyl)ethenyl]phenoxy\}oxane-2-carboxylic acid	0
3,4,5-trihydroxy-6-\{3-hydroxy-5-[2-(2-hydroxyphenyl)ethyl]phenoxy\}oxane-2-carboxylic acid	0
3,4,5-trihydroxy-6-\{3-hydroxy-5-[2-(3-hydroxyphenyl)ethyl]phenoxy\}oxane-2-carboxylic acid	0
3,4,5-trihydroxy-6-\{4-[(E)-2-(3-hydroxy-5-\{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy\}phenyl)ethenyl]phenoxy\}oxane-2-carboxylic acid	0
3,4,5-trihydroxy-6-\{4-[(E)-2-\{2,3,5-trihydroxy-4-[(1E)-3-methylbut-1-en-1-yl]phenyl\}ethenyl]phenoxy\}oxane-2-carboxylic acid	0
3,4-bis(4-hydroxyphenyl)-1-(2-phenylethyl)pyrrole-2,5-dione	0
3,4-diphenylfuran-2(5H)-one	0
3,5,6-trihydroxy-1-methyl-4,5-diphenylpiperidin-2-one	0
3,5-dihydroxy-2-(2-(2-hydroxy-6-methylphenyl)-2-oxoethyl)-4-methylbenzaldehyde	0
3,5-dihydroxy-6-carbomethoxy-2-(3-methyl-2-butenyl)bibenzyl	0
3,6-dihydroxy-4,5-diphenyl-2,3,4,5-tetrahydropyridin-2-one	0
3-(1,3-dimethyl-2-oxo-5-benzimidazolyl)-2-(2-fluorophenyl)-2-propenenitrile	0
3-(2-methoxyphenyl)-2-phenyl-2-propenoic acid [2-(2,5-dimethylanilino)-2-oxoethyl] ester	0
3-(3-nitrophenyl)-2-phenylacrylic acid	0
3-(4-morpholinyl)-2-phenyl-1-[4-(trifluoromethyl)phenyl]-1-propanone	0
3-(diethylamino)-1-(4-fluorophenyl)-2-phenyl-1-propanone	0
3-(m-Aminophenyl)-2-(p-methoxyphenyl)acrylonitrile	0
3-Methoxy-5-(2-phenylethyl)-2-prenylphenol	0
3-[2-[2-chloro-4-[[3-(2,6-dichlorophenyl)-5-propan-2-yl-4-isoxazolyl]methoxy]phenyl]ethenyl]benzoic acid	0
3-[[(3R,4S)-2-(4-bromophenyl)-5-(3-chlorophenyl)-4-(2-methoxyphenyl)-3,4-dihydropyrazol-3-yl]-oxomethyl]-2-oxazolidinone	0
3-hydroxy-1-methyl-4,5-diphenylpiperidine-2,6-dione	0
3-hydroxy-4-(4-hydroxyphenyl)-1-methyl-5-phenylpiperidine-2,6-dione	0
3-hydroxy-5-methoxy-6-prenylstilbene-2-carboxylic acid	0
3-methoxy-5-(2-phenylethenyl)phenol	0
4'-Hydroxy-3,4,5-trimethoxystilbene	0
4'-Prenyloxyresveratrol	0
4,4'-(Diphenylethenylidene)bis[N,N-dimethylbenzenamine]	0
4,4'-(ethane-1,2-diyl)bis(2,3,6-trimethoxyphenol)	0
4,4'-Dihydroxybibenzyl	0
4,4'-Dinitrostilbene	0
4,4'-dihydroxy-3,5-dimethoxydihydrostilbene	0
4,5-diphenyl-1,5-dihydroimidazol-2-one	0
4-(1-Ethyl-2-phenylbutyl)phenol	0
4-(2-Phenylethyl)phenol	0
4-(3-Methyl-1-butenyl)-3,3',4',5-tetrahydroxystilbene	0
4-(3-Methyl-2-butenyl)-5-phenethylbenzene-1,3-diol	0
4-(dimethylamino)-1-(2-hydroxyphenyl)-3-methyl-2-phenylbutan-2-yl propanoate	0
4-(dimethylamino)-3-hydroxy-3-methyl-1,2-diphenylbutan-2-yl propanoate	0
4-(dimethylamino)-3-methyl-1,2-diphenylbutan-2-ol	0
4-Acetamido-4'-isothiocyanostilbene-2,2'-disulphonic acid	0
4-Chloro-alpha-[4-[2-(diethylamino)ethoxy]phenyl]-alpha-phenylbenzeneethanol	0
4-Hydroxy-3,5,4'-trimethoxystilbene	0
4-Hydroxy-N-desmethyltamoxifen	0
4-Hydroxytamoxifen sulfate	0
4-Hydroxytamoxifen-N-glucuronide	0
4-Methoxy-6-[2-[4-(3-methylbut-2-enoxy)phenyl]ethyl]-1,3-benzodioxole	0
4-O-Methylpinosylvic acid	0
4-Prenyldihydropinosylvin	0
4-Prenylresveratrol	0
4-[(1E)-1,2-diphenylbut-1-en-1-yl]phenol	0
4-[1-Ethyl-2-(4-methylphenyl)butyl]phenol	0
4-[1-[4-[2-(dimethylamino)ethoxy]phenyl]-1-phenylbut-1-en-2-yl]phenol	0
4-[1-[4-[2-(dimethylamino)ethoxy]phenyl]-2-phenylbut-1-enyl]phenol	0
4-[2-(2-methylphenyl)-2-oxoethyl]benzamide	0
4-[2-(3,5-dihydroxyphenyl)ethenyl]benzene-1,2-diol	0
4-[2-(5,5,8,8-tetramethyl-6,7-dihydronaphthalen-2-yl)prop-1-enyl]benzoic acid	0
4-[2-[3-bromo-4-[2-(4-hydroxyphenyl)ethenyl]phenyl]ethenyl]phenol	0
4-[4-(4-hydroxyphenyl)hex-3-en-3-yl]phenol	0
4-[[(4S,5R)-4,5-bis(4-chlorophenyl)-2-(4-methoxy-2-propan-2-yloxyphenyl)-4,5-dihydroimidazol-1-yl]-oxomethyl]-2-piperazinone	0
4-[[4,5-bis(4-chlorophenyl)-2-(4-methoxy-2-propan-2-yloxyphenyl)-4,5-dihydroimidazol-1-yl]-oxomethyl]-2-piperazinone	0
5,5'-(ethane-1,2-diyl)bis(3-bromobenzene-1,2-diol)	0
5,6-diphenyl-2,3-dihydropyrazine	0
5-(2-phenylethyl)-8-quinolinol	0
5-Benzyl-2,3-bis(4-methoxyphenyl)-1,4-dimethylpiperazine	0
5-[(4-Hydroxypheny)ethenyl]-2-(3-methyl-1-butenyl)-1,3-benzenediol	0
5-[(E)-1,2-Diphenylvinyl]-2-methoxyphenol	0
5-[(E)-2-(3,4-dihydroxyphenyl)ethenyl]-2-[(1E)-4-hydroxy-3-methylbut-1-en-1-yl]benzene-1,3-diol	0
5-[(E)-2-(3,5-dihydroxyphenyl)ethenyl]-2-methoxybenzene-1,3-diol	0
5-[(E)-2-(4-hydroxyphenyl)ethenyl]-2-[(1E)-3-methylbut1,3-dien-1-yl]benzene-1,3-diol	0
5-[2-(1-cyclohexenyl)ethynyl]-6'-[2-(2-hydroxyethoxy)phenyl]-N-(2-hydroxy-2-phenylethyl)-1',2-dioxo-3',4'-diphenyl-8'-spiro[1H-indole-3,7'-4,6,8,8a-tetrahydro-3H-pyrrolo[2,1-c][1,4]oxazine]carboxamide	0
5-[2-(2,6-difluorophenyl)ethyl]-8-quinolinol	0
5-[2-(4-aminophenyl)ethenyl]benzene-1,3-diol	0
5-[2-(4-ethoxy-2-hydroxyphenyl)-2-oxoethyl]-2-benzofurancarboxylic acid	0
5-[2-(4-methoxyphenyl)ethenyl]benzene-1,3-diol	0
5-[[4-[2-cyano-2-(4-fluorophenyl)ethenyl]-2-methoxyphenoxy]methyl]-2-furancarboxylic acid	0
5-amino-2,5-dihydroxy-3,4-diphenylpentanoic acid	0
6'-Hydroxy-O-desmethylangolensin	0
6'-Hydroxyangolensin	0
6-(4-\{3-[3,5-dihydroxy-4-(3-methylbut-2-en-1-yl)phenyl]oxiran-2-yl\}-3-hydroxyphenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid	0
6-(4-\{6-[2,4-dihydroxy-3-(3-methylbut-2-en-1-yl)benzoyl]-5-\{2,6-dihydroxy-4-[(E)-2-(2,4,5-trihydroxyphenyl)ethenyl]phenyl\}-3-methylcyclohex-3-en-1-yl\}-3-hydroxyphenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid	0
6-(4-\{6-[2,4-dihydroxy-3-(3-methylbut-2-en-1-yl)benzoyl]-5-\{4-[(E)-2-(2,4-dihydroxyphenyl)ethenyl]-2,6-dihydroxyphenyl\}-3-methylcyclohex-3-en-1-yl\}-3-hydroxyphenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid	0
6-Hydroxy-4-methoxy-3-(3-methyl-2-butenyl)-2-(2-phenylethenyl)benzoic acid	0
6-O-malonyl-trans-rhaponticin	0
6-[(E)-2-(2,4-dihydroxyphenyl)ethenyl]-3-(3-methylbut-2-en-1-yl)benzene-1,2,4-triol	0
6-[2-amino-5-(4-methoxyphenyl)-6-methyl-1H-pyrimidin-4-ylidene]-3-(2-methylprop-2-enoxy)-1-cyclohexa-2,4-dienone	0
6-[4-(2,3-dihydro-1,4-benzodioxin-6-yl)-5-methyl-1,2-dihydropyrazol-3-ylidene]-4-ethyl-3-hydroxy-1-cyclohexa-2,4-dienone	0
6-[4-(3,4-dimethoxyphenyl)-1,2-dihydropyrazol-3-ylidene]-3-[(4-nitrophenyl)methoxy]-1-cyclohexa-2,4-dienone	0
6-[4-(4-methoxyphenyl)-1,2-dihydropyrazol-3-ylidene]-3-(2-methylprop-2-enoxy)-1-cyclohexa-2,4-dienone	0
6-[6-(2,4-dihydroxyphenyl)-2-\{4-[(E)-2-(2,4-dihydroxyphenyl)ethenyl]-2,6-dihydroxyphenyl\}-4-methylcyclohex-3-ene-1-carbonyloxy]-3,4,5-trihydroxyoxane-2-carboxylic acid	0
6-[6-(2-\{2,6-dihydroxy-4-[(E)-2-(2,4,5-trihydroxyphenyl)ethenyl]phenyl\}-6-(2,4-dihydroxyphenyl)-4-methylcyclohex-3-ene-1-carbonyl)-3-hydroxy-2-(3-methylbut-2-en-1-yl)phenoxy]-3,4,5-trihydroxyoxane-2-carboxylic acid	0
6-\{2-[2-(2,4-dihydroxyphenyl)-2-oxoethyl]-5-hydroxy-3-methoxy-4-(3-methylbut-2-en-1-yl)phenoxy\}-3,4,5-trihydroxyoxane-2-carboxylic acid	0
6-\{2-[6-carboxy-5-(2,4-dihydroxyphenyl)-3-methylcyclohex-2-en-1-yl]-5-[(E)-2-(2,4-dihydroxyphenyl)ethenyl]-3-hydroxyphenoxy\}-3,4,5-trihydroxyoxane-2-carboxylic acid	0
6-\{3-[2-(2,5-dihydroxyphenyl)ethyl]-5-methoxyphenoxy\}-3,4,5-trihydroxyoxane-2-carboxylic acid	0
6-\{3-[2-(3,5-dihydroxyphenyl)ethyl]phenoxy\}-3,4,5-trihydroxyoxane-2-carboxylic acid	0
6-\{4-[(E)-2-\{3,5-dihydroxy-4-[(1E)-3-hydroxy-3-methylbut-1-en-1-yl]phenyl\}ethenyl]phenoxy\}-3,4,5-trihydroxyoxane-2-carboxylic acid	0
6-\{4-[(E)-2-\{4-[6-carboxy-5-(2,4-dihydroxyphenyl)-3-methylcyclohex-2-en-1-yl]-3,5-dihydroxyphenyl\}ethenyl]-3-hydroxyphenoxy\}-3,4,5-trihydroxyoxane-2-carboxylic acid	0
6-\{4-[2-(2,4-dihydroxyphenyl)-2-oxoethyl]-5-hydroxy-3-methoxy-2-(3-methylbut-2-en-1-yl)phenoxy\}-3,4,5-trihydroxyoxane-2-carboxylic acid	0
6-\{5-[(E)-2-(3,4-dihydroxyphenyl)ethenyl]-3-hydroxy-2-[(1E)-3-methylbuta-1,3-dien-1-yl]phenoxy\}-3,4,5-trihydroxyoxane-2-carboxylic acid	0
6-\{5-[(E)-2-(3,5-dihydroxyphenyl)ethenyl]-2-methoxyphenoxy\}-3,4,5-trihydroxyoxane-2-carboxylic acid	0
6-\{6-[6-(2,4-dihydroxyphenyl)-2-\{4-[(E)-2-(2,4-dihydroxyphenyl)ethenyl]-2,6-dihydroxyphenyl\}-4-(hydroxymethyl)cyclohex-3-ene-1-carbonyl]-3-hydroxy-2-(3-methylbut-2-en-1-yl)phenoxy\}-3,4,5-trihydroxyoxane-2-carboxylic acid	0
6-\{6-[6-(2,4-dihydroxyphenyl)-2-\{4-[(E)-2-(2,4-dihydroxyphenyl)ethenyl]-2,6-dihydroxyphenyl\}-4-methylcyclohex-3-ene-1-carbonyl]-3-hydroxy-2-(3-methylbut-2-en-1-yl)phenoxy\}-3,4,5-trihydroxyoxane-2-carboxylic acid	0
8'-[1-azocanyl(oxo)methyl]-6'-[2-(2-hydroxyethoxy)phenyl]-3',4'-diphenylspiro[1H-indole-3,7'-4,6,8,8a-tetrahydro-3H-pyrrolo[2,1-c][1,4]oxazine]-1',2-dione	0
Adlumidiceine	0
Alpha-Hydroxy-tamoxifen-O-glucuronide	0
Amorfrutin A	0
Amycolabenzoside A	0
Amycolabenzoside B	0
Aqabamycin A	0
Aqabamycin B	0
Aqabamycin C	0
Aqabamycin D	0
Artocarbene	0
Ascomindone A	0
Ascomindone B	0
BMS-453	0
BMS-493	0
Batatasin II	0
Batatasin III	0
Batatasin IV	0
Benvitimod	0
Benzene, 1,3-dimethoxy-5-(2-phenylethyl)-	0
CAY10616	0
Chlorophorin	0
Combretastatin A4	0
Demethylbatatasin IV	0
Desoxyrhaponticin	0
Diethylstilbestrol dimethyl ether	0
Diethylstilbestrol monomethyl ether	0
Diethylstilbestrol monosulfate	0
Dimethylstilbestrol	0
Discoipyrrole B	0
Discoipyrrole C	0
Discoipyrrole D	0
Droloxifene	0
Endoxifen sulfate	0
Ethamoxytriphetol	0
Fispemifene	0
G b1-G	0
GW 4064	0
Gaylussacin	0
Glepidotin C	0
Glicophenone	0
Hexestrol monomethyl ether	0
Homoclausenamide	0
Icariside E5	0
Idoxifene	0
Isoravenelone	0
Isorhapontigenin	0
Isorhapontin	0
Kocumarin	0
LSM-10158	0
LSM-10817	0
LSM-10952	0
LSM-14326	0
LSM-15164	0
LSM-15165	0
LSM-15166	0
LSM-2293	0
LSM-25341	0
LSM-25427	0
LSM-25443	0
LSM-25554	0
LSM-25594	0
LSM-30919	0
LSM-30949	0
LSM-31033	0
LSM-31136	0
LSM-3156	0
LSM-32014	0
LSM-36486	0
LSM-36488	0
LSM-36499	0
LSM-36502	0
LSM-36516	0
LSM-36521	0
LSM-36524	0
LSM-36527	0
LSM-36530	0
LSM-36535	0
LSM-36538	0
LSM-36543	0
LSM-36560	0
LSM-36585	0
LSM-37329	0
LSM-37359	0
LSM-37541	0
LSM-37607	0
LSM-37686	0
LSM-37688	0
LSM-37763	0
LSM-37818	0
LSM-38122	0
LSM-38169	0
LSM-38290	0
LSM-38370	0
LSM-38388	0
LSM-38591	0
LSM-38601	0
LSM-38772	0
LSM-38795	0
LSM-38819	0
LSM-38929	0
LSM-38931	0
LSM-38988	0
LSM-39133	0
LSM-39555	0
LSM-39628	0
LSM-39641	0
LSM-39795	0
LSM-39933	0
LSM-39981	0
LSM-40016	0
LSM-40078	0
LSM-40283	0
LSM-40335	0
LSM-40342	0
LSM-40463	0
LSM-40740	0
LSM-40782	0
LSM-40858	0
LSM-40879	0
LSM-40882	0
LSM-40920	0
LSM-40958	0
LSM-41014	0
LSM-41021	0
LSM-41042	0
LSM-41094	0
LSM-41206	0
LSM-41267	0
LSM-41324	0
LSM-41329	0
LSM-41367	0
LSM-41450	0
LSM-41475	0
LSM-41813	0
LSM-41881	0
LSM-41924	0
LSM-41934	0
LSM-41942	0
LSM-42016	0
LSM-42024	0
LSM-42106	0
LSM-42235	0
LSM-42264	0
LSM-42314	0
LSM-42427	0
LSM-42465	0
LSM-42468	0
LSM-42473	0
LSM-42537	0
LSM-42666	0
LSM-6991	0
LSM-7019	0
LSM-7029	0
LSM-7035	0
LSM-7046	0
LSM-7170	0
LSM-7212	0
LSM-7363	0
LSM-7460	0
LSM-7495	0
LSM-7560	0
LSM-7622	0
LSM-7741	0
LSM-7770	0
LSM-7838	0
LSM-7866	0
LSM-7904	0
LSM-7915	0
LSM-8088	0
LSM-8412	0
Lansamide 3	0
Lefetamine hydrochloride	0
Licoagrodione	0
Licoriphenone	0
Longistylin A	0
Longistylin C	0
Lucidumin B	0
Lunularic acid	0
Lunularin	0
Machaeriol C	0
Metaflumizone	0
Methoxy hydroxy stilbene carboxylic acid	0
Methyl 3-anilino-2-(1,7-dimethyl-1H-indol-3-yl)-2,3-diphenylpropanoate	0
N,2,3-triphenyl-2-propenamide	0
N,N-Didesmethyltamoxifen	0
N-(2,6-diethylphenyl)-2,3-diphenyl-2-propenamide	0
N-Desmethyltamoxifen	0
N-Methylnarceimicine	0
N-desmethyltoremifene	0
N-ethyl-5-(4-hydroxy-6-oxo-3-propan-2-yl-1-cyclohexa-2,4-dienylidene)-4-[4-(4-morpholinylmethyl)phenyl]-2H-isoxazole-3-carboxamide	0
NCGC00385051-01	0
Narceine	0
Narceinone	0
Nicofetamide	0
Norendoxifen	0
Norpropoxyphene	0
O-Desmethylangolensin	0
Oxyresveratrol	0
Phenol, 5-[(1z)-2-(3,5-dimethoxyphenyl)ethenyl]-2-methoxy-	0
Piceatannol 3,4'-diglucoside	0
Piceatannol 4'-galloylglucoside	0
Piceatannol 4'-glucoside	0
Pinostilbenoside	0
Pinosylvin methyl ether	0
Pulveraven A	0
Pulveraven B	0
Radulannin A	0
Radulannin H	0
Radulannin L	0
Ravenelone	0
Resveratrodehyde A	0
Resveratrodehyde B	0
Resveratrodehyde C	0
Resveratrol 4'-(2-galloylglucoside)	0
Resveratrol 4'-(6-galloylglucoside)	0
Rhapontigenin	0
S-3-hydroxy-4,5-diphenylfuran-2(5H)-one	0
SC-57666	0
Salvianolic acid A	0
Sarpogrelate hydrochloride	0
Stilbostemin F	0
Sucrose 1',4'-(4,4'-dihydroxy-3,3'-dimethoxy-b-truxinate)	0
Sumarotene	0
Taranabant	0
Tetraphenylcyclopentadienone	0
Toremifene citrate	0
Trimethyl(\{2-[4-(2-\{4-[2-(trimethylazaniumyl)ethoxy]phenyl\}pentyl)phenoxy]ethyl\})azanium diiodide	0
Triphenylethylene	0
Verimol D	0
[(4-\{3-[2-(2,4-dihydroxyphenyl)-2-oxoethyl]-4,6-dihydroxy-2-methoxyphenyl\}-2-methylbut-2-en-1-yl)oxy]sulfonic acid	0
[4-(2-phenylcyclobutyl)phenyl]oxidanesulfonic acid	0
[4-(3-\{3,5-dihydroxy-4-[(1E)-3-methylbut-1-en-1-yl]phenyl\}oxiran-2-yl)phenyl]oxidanesulfonic acid	0
[4-methoxy-2-[2-[5-methoxy-2-(oxidoazaniumyl)phenyl]ethyl]phenyl]-oxidoazanium	0
\{4-[(1e)-4-chloro-1,2-diphenyl-1-buten-1-yl]phenoxy\}acetaldehyde	0
\{4-[(E)-2-\{3,5-dihydroxy-4-[(1E)-3-methylbut-1-en-1-yl]phenyl\}ethenyl]phenyl\}oxidanesulfonic acid	0
\{4-[3-(3,5-dihydroxyphenyl)oxiran-2-yl]phenyl\}oxidanesulfonic acid	0
acetic acid [4-[2-(3,5-diacetyloxyphenyl)ethenyl]phenyl] ester	0
aiphanol	0
alpha,alpha'-Diethyl-3,4,4'-stilbenetriol	0
alpha,alpha'-Diethyl-4,4'-bis(2-propynyloxy)stilbene	0
alpha-Ethyl-alpha,beta-diphenyl-2-pyridineethanol	0
alpha-Hydroxy-N-desmethyltamoxifen	0
alpha-Hydroxytamoxifen	0
aminoxytriphene	0
ampelopsin B	0
bibenzonium	0
cinnamaverine	0
cis-Mulberroside A	0
cis-Resveratrol 3-sulfate	0
cis-Resveratrol 4'-O-glucuronide	0
cis-Resveratrol 4'-sulfate	0
cis-astringin	0
cis-piceid	0
diethylaminoethoxyhexestrol	0
florbetaben ((18)F)	0
hexestrol	0
hydroxystilbamidine	0
lefetamine	0
lignin cw compound-172	0
lignin cw compound-2019	0
lignin cw compound-2053	0
lignin cw compound-2054	0
lignin cw compound-3007	0
lignin cw compound-3030	0
m-(beta-Acetyl-alpha-ethyl-p-hydroxyphenethyl)benzoic acid	0
methestrol	0
methestrol dipropionate	0
nepalensinol D	0
nepalensinol E	0
nepalensinol F	0
p-Methoxystilbene	0
pallidol	0
palovarotene	0
pheniodol sodium	0
phoyunbene A	0
phoyunbene B	0
phoyunbene C	0
phoyunbene D	0
poacic acid	0
pyrrobutamine	0
quadrangularin A	0
rhaponticin +	0
sarpogrelate	4
schweinfurthin E	0
schweinfurthin F	0
schweinfurthin G	0
schweinfurthin H	0
stilbenol +	226
tamoxifen +	1
trans-2-(4-Methoxyphenyl)-3-(4-nitrophenyl)oxirane	0
trans-Resveratrol 3,4'-disulfate	0
trans-Resveratrol 3,5-disulfate	0
trans-Resveratrol 3-O-glucuronide	0
trans-Resveratrol 4'-O-glucuronide	0
trans-astringin	0
trans-diptoindonesin B	0
trans-piceid	0
triparanol	0
vedelianin +	0
zuclomifene	0

paths to the root